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During human hemostatic and inflammatory responses, cell adhesion molecules 
play a major role in regulating the way that leukocytes and platelets adhere to vascular 
surfaces in the hydrodynamic environment of blood circulation. Flow requirements have 
been reported for these cell adhesion events in vivo. Shear threshold and catch bonds 
have a close relationship for adhesion events, but need to be further elucidated. The 
structural basis to explain the mechanism by which catch bonds work is mostly 
hypothetical and also needs further investigation. 
By studying the structure-function relationship of vascular adhesion molecules, 
such as L-selectin, GPIb-VWF, and ADAMTS13, which are involved in regulation of 
leukocyte and platelet adhesion to the vascular wall, we quantify the effects of three 
specific point mutations on L-selectin on its interaction kinetics with 2-GSP-6 and 6-
sulfo-sLe
x
, we characterize the kinetics of GPIbα as it interacts with the VWF A1 
domain, and we characterize the kinetics of ADAMTS13 as it interacts with the VWF 
A1A2A3 tri-domain and we characterize its cleavage effects on A1A2A3. The overall 
project goal is to study how mechanical force regulates the binding kinetics of these 
proteins. These novel results are crucial in that they provide kinetics information on the 
single molecule level unlike the traditional biochemical binding assays. The biophysical 
measurements that are obtained using the single molecule technique help us to better 
understand how individual molecules behave in this mechanically stressful environment. 
The structural mutants of these proteins, which have been found to alter binding kinetics, 
suggest a possible molecular mechanism for either cell adhesion behavior (such as flow-
 xvii
enhanced adhesion), or certain diseases (such as VWD and TTP). Understanding the 
molecular mechanism is crucial for disease diagnosis and treatments. 
Selectin-ligand interactions (bonds) mediate the way leukocytes roll on vascular 
surfaces. The molecular basis for differential ligand recognition by selectins is poorly 
understood. Atomic force microscopy is used to compare the kinetics of wild-type L-
selectin with the kinetics of three mutants of L-selectin interacting with 2-GSP-6; these 
mutants are a synthetic glycosulfopeptide modeled after the binding site of PSGL-1, and 
6-sulfo-sLe
x
, and a synthetic glycan prototypical of PNAd. Rather than first prolong 
(catch) and then shorten (slip) bond lifetimes, increasing force monotonically shortened 
the lifetimes of L-selectin MutI (A108H+H110A) and MutIA (A108H) bonds with 2-
GSP-6. MutIB (H110A) exhibited an augmented catch bond. L-selectin also formed 
catch-slip transitional bonds with 6-sulfo-sLe
x
. In sharp contrast, MutI, MutIA and MutIB 
had no effect on the bond lifetimes. These results distinguish molecular mechanisms for 
L-selectin to bind to PSGL-1 and PNAd. 
Although catch bonds have been observed for selectins interacting with their 
ligands, it is still not clear whether other cell adhesion molecules also exhibit catch bond 
behavior. The interaction between glycoprotein Ib (GPIb) and the von Willebrand Factor 
(VWF) mediates platelet translocation at the vascular vessel damage sites, which plays a 
critical role in initiating platelet adhesion and thrombus formation. Similar to L-selectin-
mediated tethering and rolling of leukocytes, translocation of platelets on VWF requires a 
shear threshold, suggesting a possible catch bond at work there. We characterized the 
kinetics of GPIbα interacting with the VWF A1 domain, confirming that the catch bond 
existed. Two type 2B VWD A1 mutants eliminated the catch bond and gave longer low 
 xviii 
force lifetimes. The prolonged lifetimes at low force resulted in more agglutination of 
platelets with A1 coated microspheres in flow. Three type 2M VWD A1 mutants showed 
shifted catch-slip transitional bonds that exhibited shorter lifetimes at low force but 
longer lifetimes at high force level. A2A3 domains affected the GPIbα-A1 catch bond 
quantitatively. Type III collagen’s capturing of A1 or A1A2A3 also quantitatively shifted 
their bond lifetimes with GPIbα, indicating that A1 could have different conformational 
states. 
During the process of hemostasis, the size of prothrombotic ULVWF affects the 
affinity of VWF to platelets bearing GPIbα on the membrane. Seven years ago, 
ADAMTS13 was identified and characterized as a multi-domain metalloprotease that can 
cleave at the Tyr1605-Met1606 bond of VWF, thus regulating the size of ULVWF. We 
studied how force regulated the binding and cleavage of ADAMTS13 on VWF. The full 
length ADAMTS13 molecule formed catch-slip transitional bonds with A1A2A3 while 
CUB domains (CUB1&2) only formed slip bonds, suggesting that shear force may play a 
role in facilitating the enzyme’s binding to its substrate. By utilizing the analysis of two 
force drop events, we found the cleavage effects could only be observed after the 
catastrophic structural change of A1A2A3. The putative uncoupling of A1 from the A2 
domain could only have 14nm contour length increment and would not favor cleavage 
before A2 unfolding. The putative unfolding of the A2 domain would have much longer 
contour length increment capacity, depending on how many β-sheets would be pulled out 
of the A2 domain. Unfolding the A2 domain exposed the ADAMTS13 cleavage site and 
favored the cleavage. Two protocols using different stretching molecules (GPIbα and 
CR1) and A1A2A3 immobilization methods (physical adsorption and anti-His capturing 
 xix
A3) revealed that the cleavage effects diminished with increases in stretching force. 
Regardless of single bond kinetics, time-to-unfold exhibited catch bond behavior for both 
stretching protocols, suggesting that catch bonds could also be observed during the 
domain internal structural change. 
This study elucidated mechanisms of the binding kinetics of L-selectin with 
different structural components from PSGL-1 and PNAd by structural variants. It also 
provided new insights into our current knowledge of the dynamic adhesion and regulation 
of GPIbα-VWF interaction in vivo. Using the single molecule method, the chemical 
catalytic reaction between enzyme and substrate has been targeted. The results help 










 The following aims were proposed to investigate the structure-function 
relationship of vascular tethering molecules’ binding kinetics, including L-selectin vs. 
PSGL-1/PNAd, GPIbα vs. VWF, ADAMTS13 vs. VWF, and ADAMTS13’s cleavage 
effects on VWF. 
 
Aim 1: Quantify the effects of three specific point mutations on L-selectin on the 
interaction kinetics with 2-GSP-6 and 6-sulfo-sLe
x
 
This task will compare the kinetics of three mutants (MutI, MutIA, and MutIB) of 
L-selectin interacting with 2-GSP-6, a synthetic glycosulfopeptide modeled after the 
binding site of P-selectin glycoprotein ligand 1 (PSGL-1), and 6-sulfo-sLe
x
 (sialyl Lewis 
x), a synthetic glycan prototypical of peripheral node addressin (PNAd), with the kinetics 
of wild-type (WT) L-selectin. MutI (A108H and H110A), MutIA (A108H), and MutIB 
(H110A) are predicted to affect the off-rate and the catch bond between L-selectin and 
PSGL-1 but not to affect PNAd. The force regulation of off-rate will be measured using 
atomic force microscopy (AFM). This aim is designed to answer the following question: 
• How do the structural variations in L-selectin affect the catch bond observed in 
WT L-selectin dissociating from PSGL-1 and from PNAd? 
 
Aim 2: Characterize the kinetics of GPIbα as it interacts with VWF A1 domain 
Although catch bonds have been observed for selectins interacting with their 
ligands, it is still not clear whether other cell adhesion molecules also exhibit catch bond 
behavior. The interaction between glycoprotein Ib (GPIb) and von Willebrand Factor 
(VWF) mediates platelet translocation at vascular vessel damage sites, which plays a 
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critical role in initiating platelet adhesion and thrombus formation. Similar to L-selectin-
mediated tethering and rolling of leukocytes, translocation of platelets on VWF requires a 
shear threshold, suggesting a possible catch bond at work there. Type 2B and type 2M 
von Willebrand Disease A1 mutants have different affinities with GPIb, indicating 
different binding kinetics. In the VWF molecule, A2A3 domains may also potentially 
affect A1’s binding with GPIb, in the presence or absence of collagen immobilization. 
This aim will address the following questions: 
• Do interactions of GPIb with VWF A1 domain exhibit catch bond behavior? 
• How do the type 2B and type 2M VWD A1 mutants affect the binding kinetics of 
A1 interacting with GPIb? 
• How does A2A3 domain and collagen immobilization affect the binding kinetics 
of A1 interacting with GPIb? 
 
Aim 3: Characterize the kinetics of ADAMTS13 interacting with VWF A1A2A3 domain 
triplet and its cleavage effects on A1A2A3 
ADAMTS13 has been identified as an important enzyme for binding and 
processing the VWF molecule in blood plasma. The cleavage of VWF plays a vital role 
in controlling the size and amount of prothrombotic ULVWF in the plasma. The 
mechanism of this enzyme-substrate interaction is not clearly understood yet. Shear stress 
enhances the cleavage of ADAMTS13, and it is hypothesized that shear stress favors the 
unfolding of the A2 domain and that it exposes the cleavage site for ADAMTS13. To test 
the role of force in regulating the enzyme cleavage, we will address the following 
questions in this aim: 
• How does force regulate the binding kinetics of ADAMTS13 and its structural 
variant with A1A2A3? 
• How does force induce the unfolding of A2 domain and regulate the cleavage of 





Cell Adhesion in the Vascular System 
Cell adhesion is essential for the development and maintenance of multicellular 
organisms(1). Cell adhesion is crucial to all developmental processes, but has a central 
role in the functions of the immune system throughout life(2). During the inflammation 
cascade, leukocytes tether to and roll on the activated endothelial cells of the 
inflammation site due to the interaction between PSGL-1 on leukocytes and P-selectin on 
activated endothelial cells and platelets(3). These adhesion events serve as the first step 
for the inflammation site to recruit patrolling leukocytes in the blood. When lymphocytes 
are homing to the lymph nodes, they need first to adhere to the endothelial cells of HEV 
(High Endothelial Venue) by the interaction of L-selectin with PNAd (Peripheral Node 
Addressin). This initiates the rolling and subsequent firm adhesion and transmigration 
processes which involve integrin and receptors(1, 3-5). 
As leukocyte adhesion is important for the inflammation response, platelet 
adhesion plays an important role in hemostasis. Patrolling platelets adhere to and roll on 
the subendothelium exposed after the endothelium lining is damaged by vascular 
injury(6, 7). Initial adhesion through GPIb (Glycoprotein Ib) expressed on platelets 
binding to immobilized VWF (von Willebrand Factor) slows down the platelets. GPIb-
VWF binding also triggers signaling inside the platelets and initiates the following firm 
adhesion through integrin and receptors. Integrin-involved platelet-platelet adhesion 
helps bring more platelets to the injury site to form a thrombus(6).  
Upon activation, endothelial cells express long strings of ULVWF (ultra-large 
von Willebrand factor) immobilized on their surface by P-selectin or collagen. The 
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adhesion of flowing platelets to the immobilized hyper-adhesive ULVWF applies 
stretching force and induces conformational change on the molecule, which could 
facilitate cleavage of ADAMTS13, making smaller pieces of VWF multimers(8). 
Endothelial cells and platelet-derived ADAMTS13 could be physiologically important in 
processing VWF molecules in the multiple binding events that are involved in thrombus 
formation during hemostasis(9, 10). 
2D Binding Assays of Receptor-Ligand Interactions 
Under physiological conditions, cell adhesion molecules interact in two rather 
than three dimensions. Among those techniques that can be employed to measure 
receptor-ligand interactions in two dimensions, AFM (atomic force microscopy) allows 
measurement of molecular interactions subjected to small forces in the pico-Newton 
range. AFM is an established method in the Zhu lab (11, 12). In AFM, a laser light is shot 
on a reflective surface (usually golden) of a cantilever tip; the reflected light is captured 
by a photodiode detector, which can monitor subtle shifts of the laser spot position and 
can transform such shifts to voltage changes and force by relating sensitivity (V/nm) and 
cantilever spring constant (pN/nm) (Figure 2.1).  
In single molecule mechanics studies, actuated by the elongated piezo tube, a 
ligand-coupled cantilever tip is brought into contact with a receptor, usually coated on the 
Petri dish or incorporated into a lipid bilayer on a cover slip. A binding event can be 
detected when the cantilever is retracted away from the surface because a tensile force, 
applied to the molecular interaction, causes the cantilever to bend. Dissociation of the 
binding interaction causes the cantilever to spring back and return to the force-free 
condition. The lifetime of the bond under constant force provides information about the 
bond dissociation rate: the longer the mean bond lifetime, the lower the bond dissociation 
rate. The ascending phase for loading the bond with force (Figure 2.1 right panel) 
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provides information regarding molecular mechanical properties including the bond’s 
spring constant. The measurement distributions from hundreds of such binding events on 
different force scales provide information about the force-dependent lifetimes (off-rates), 











Figure 2.1: Schematic of AFM system (left) and force scan curves (right). Initially, 
the approach tracing was flat (zero mean force) but bent downward (negative force) 
when the tip was pressed onto the Petri dish. After touching the Petri dish surface, 
AFM cantilever was retracted to a distance above the surface and held there for 0.5 
seconds to fish adhesion events. Then the PZT was retracted further to load the 
bond, if there was one, with predetermined force, i.e., 20pN. In this case, the 
retraction tracing was bent upward, indicating a tensile force that was applied to the 
tip through a molecular bond linked to the protein coated on Petri dish. In the 
rupture force experiment, the cantilever was continuously retracted until the bond 
broke and the tip sprang back to the unbent position (right red tracing). In the bond 
lifetime experiment, once it reached a predetermined adhesion force, the PZT would 
stop to hold the cantilever position and would apply a constant force to the bond 
until rupture (right black tracing). (11, 13) 
 
Another important technique that complements AFM experiments uses the flow 
chamber. The flow chamber methods use a parallel-plate flow chamber in which purified 
molecules or cultured cell monolayers can be incorporated on the chamber floor(14, 15). 
Resembling the initial tethering and rolling of patrolling leukocytes/platelets in the 
vasculature, cells or microspheres with ligands expressed or coupled on the surface are 
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perfused through the chamber at various flow rates. Adhesion events can be visualized by 
video microscopy and can be further analyzed by software to get more details. Adhesion 
parameters that can be obtained include tether lifetimes (rates) and rolling velocities, etc. 
 
Force Regulation of Bond Kinetics 
Cell-surface ligands interact with selectins or GPIb to mediate tethering and 
rolling of flowing leukocytes or platelets on vascular surfaces; they act in response to 
infection or tissue injury(4, 7, 16). In this mechanically stressful environment, different 
forces are applied to receptor-ligand bonds at various rates. The relationship between off-
rate and force partly determines how efficiently tethers produce rolling and how rapidly 
and stably cells roll(15). 
Bell was the first to suggest that force could influence the dissociation of adhesive 
receptor-ligand bonds(17). Published work to date has revealed that the bond dissociation 
rate (off-rate) depends not only on the instantaneous force level(17-19), but also on the 
history of the force loading on the bonds(20). These observations have become the basis 
for different measurements determining off-rate regulation by forces applied on the 
bonds. One such measurement focuses on bond lifetimes recorded in a range of constant 
forces. Bond lifetime measurements have been made using flow chambers (14, 15, 21-
27), atomic force microscopy (AFM)(11, 12, 28, 29), and biomembrane force probes 
(BFP)(30). Another type of measurement records bond rupture forces under a range of 
constant loading rates, and data can be further analyzed by dynamic force spectroscopy 
(DFS)(19, 31-33). 
 
Catch Bonds and Shear Threshold 
In 1988, Dembo was the first to hypothesize the existence of catch bonds, where 
increasing force prolonged bond lifetime (decreased bond off-rate)(18). It was not until 
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fifteen years later that this counter-intuitive mechamism for force regulated bond 
dissociation was first experimentally observed(11). Using AFM and transient tether 
lifetime measurements in the flow chamber, P- and L-selectin both showed catch bonds 
in lower force regimes when interacting with (s)PSGL-1(11, 12). At higher force ranges, 
the bond behaved as a slip bond. The specificity of catch bond behavior in P- and L-
selectin/(s)PSGL-1 was confirmed by comparison with P-selectin/G1 and L-
selectin/DREG56, antigen/antibody interactions showing only slip bonds, which can be 
well described by the Bell model. Catch-slip transitions were also observed for L-selectin 
interacting with endoglycan, a newly identified PSGL-1-like ligand(34, 35). 
Under physiological conditions in the vascular system, selectins require a 
threshold shear to support cell adhesion(22, 36, 37). As shear drops below the threshold 
level, fewer flowing cells tether, the cells roll more rapidly and irregularly, and they 
begin to detach. Similarly, platelets also require arterial flow rates to adhere to the von 
Willebrand factor, immobilized on damaged vascular surfaces(7, 38). It is 
counterintuitive that the application of increased shear force on adhesion bonds actually 
stabilizes the tethering and rolling of the platelets. It has been hypothesized that flow 
increases the bonds’ on-rates thus facilitating bond formation. That is, flow rate increases 
could improve the transport of adhesion molecules to their ligands so that more bonds 
will form before they dissociate(36, 39, 40). Another factor for shear-enhanced adhesion 
could be from increased cell surface contact area, which brings more adhesion molecules 
to the contact area(41, 42). An alternative hypothesis concerning the catch bond 
mechanism is that force prolongs bond lifetime and thus stabilizes rolling. Yago et al. 
measured the independent effects of transport, tether force, and contact area on transient 
tether and rolling of L-selectin-bearing microspheres or cells on PSGL-1 below and 
above the shear optimum(15). These results demonstrated that rolling below optimal 
shear was governed by catch bonds, whereas slip bonds govern rolling above optimal 
shear. By these carefully designed experiments, it was also found that tether force, not 
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shear rate, governed rolling velocity and rolling regularity below and above the flow 
optimum. Thereby, it was concluded that force-induced prolongation of L-selectin bond 
lifetime is essential for flow-enhanced cell adhesion. 
 However, Evans and colleagues used a biomembrane force probe showing that 
off-rates depend on precisely how the force is applied(33, 43). They found that the L-
selectin-PSGL-1 bond is a slip bond, and with the molecules displaying two separate 
energy barriers to dissociation. From this point of view, the mechanism for catch bonds 
lies in how precisely the forces are applied to the molecules, with an overlap between 
different energy barriers leading to apparent catch bond behavior(33, 44). These works 
provide several possible different explanations of the shear threshold phenomenon, and 
the problem requires further investigation. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
Proteins and Glycoconjugates 
 To study the force regulated binding kinetics of L-selectin with its ligands (PSGL-
1 and PNAd derivatives), we used the following proteins and glycoconjugate constructs. 
L-selectin-Ig containing the lectin domain, EGF domain, and both consensus repeats of 
human L-selectin fused to the Fc moiety of human IgG that was described 
previously(12). The L-selectin-Ig chimera was purified from supernatants by protein G 
affinity chromatography and sent to us generously by Dr McEver’s lab. The blocking 
antibody DREG56 for L-selectin (45) and PL1 for 2-GSP-6 (46) have been described 
previously. Goat anti-human IgG Fc polyclonal antibody was purchased from Chemicon 
(Temecula, CA). L-selectin lectin domain mutants were also sent to us by Dr McEver’s 
lab. MutI has two point residue replacements at A108H and H110A; MutIA and MutIB 
have only a single point residue replacement, at A108H and H110A, respectively. As 
important ligands to bind L-selectin, biotinylated human P-selectin glycoprotein ligand-1 
(PSGL-1) N-terminus peptide 2-GSP-6 and monomeric 6-sulfo-sialyl Lewis X (6-sulfo-
sLe
x
) as PNAd binding surrogate was described previously(47, 48). GPIbα molecules 
were expressed and purified from CHO (Chinese Hamster Ovary) cells by the labs of Dr 
Lopez and Dr Dong. Gain-of-function and loss-of-function VWF-A1 mutants as well as 
VWF A1A2A3 tridomain constructs were provided by Dr Cruz’s lab. Type III collagen 
from human placentas was purchased from Sigma. Recombinant ADAMTS13 and CUB 
(CUB1 & CUB2) domains are provided by Dr Dong. Anti-6-Histidine antibody was 
purchased from Sigma. A1 domain monoclonal antibody CR1 was a generous gift from 
Dr Berndt. EDTA was purchased from Sigma. 
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Coupling of Proteins to Surface 
 WT/Mutant L-selectin-Ig was captured by 10µg/ml of goat-anti-human Fc IgG, 
10µl of which was incubated on the Petri dish at 4 
o
C overnight. The labeled incubation 
spot was washed three times by TSA (Tris Saline Azide) buffer to remove excess IgG 
from the surface. Then 5µl of WT/Mutant L-selectin-Ig (5µg/ml) was added on the spot 





containing 1% BSA (bovine serum albumin) without IgG, the incubation spot was 
washed once, then a Petri dish was filled with 8ml of this buffer. 
Cantilever tips were incubated overnight at 4
o
C in 10µg/ml Streptavidin (Pierce). 
After rinsing once by PBS, the coated cantilevers were incubated for 30 min at room 




) containing 1% BSA (without IgG) to block 
nonspecific adhesion. Streptavidin-coated cantilevers were further functionalized by 
incubation in 10µl of 100ng/ml biotinylated 2-GSP-6 or 6-sulfo-sLe
x
 for 20 min at room 
temperature for specific adhesion experiments. 
For studying the GPIb/VWF interaction, spots on the Petri dish were incubated by 
10µl of 10ug/ml VWF-A1 (WT or mutant) or A1A2A3 tridomain overnight at 4
o
C. 
Excess protein was removed after incubation by rinsing with PBS. PBS with 1% BSA 
buffer was added to the Petri dish to block non-specific binding. The AFM tip was 
incubated by 10µl of 10ug/ml glycocalicin, which is the extracellular domain of GPIbα. 
When using collagen capturing, 10µl of 15ug/ml type III collagen was incubated first on 
the Petri dish, then VWF-A1 or A1A2A3 (5µl 5ug/ml) was incubated secondarily to be 
captured by collagen.  
 When studying the ADAMTS13/A1A2A3 interaction, 10µl of 10ug/ml 
ADAMTS13 or CUB protein was incubated on the AFM tip; 10µl of 10ug/ml A1A2A3 
was incubated on a Petri dish. A GPIb or CR1 coated tip was used to stretch the A1A2A3 
tridomain. ADAMTS13 (5ug/ml) with/without EDTA (5mM) was added in the buffer 




BINDING KINETICS OF L-SELECTIN WITH STRUCTURAL 




The interactions of selectins with cell-surface ligands initiate rolling of leukocytes 
on activated endothelial cells or on activated platelets (Figure 4.1). The homing of 
lymphocytes into lymph nodes and the recruitment of leukocytes to sites of inflammation 
are multistep processes; selectins are essential in regulating the critical rolling phase of 
leukocyte adhesion (49). Named by the cell types they are expressed on, L-selectin is 
expressed on most leukocytes and binds ligands on endothelial cells and other leukocytes; 
P-selectin is expressed on activated platelets and endothelial cells, and it binds ligands on 
leukocytes and, in some cases, on endothelial cells; E-selectin is expressed on activated 








Figure 4.2: Interactions of selectins with cell-surface ligands initiate rolling of 
leukocytes to activated endothelial cells and thereby trigger the adhesion cascade. 
(Adapted from (4, 5)) 
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Whereas L-selectin is constitutively and exclusively expressed on leukocyte 
membranes, the expression of P- and E-selectins is induced by inflammatory mediators 
such as thrombin or histamine(4). P-selectin is constitutively synthesized by 
megakaryocytes and endothelial cells, where it is sorted into the α-granules in platelets 
and Weibel-Palade bodies in endothelial cells. Upon cellular activation by mediators, P-
selectin is redistributed to the cellular membrane. E-selectin is synthesized by activated 
endothelial cells induced by the inflammatory mediators such as TNF-α, IL-1β, or LPS 









Figure 4.3: Domain organization of the selectins. Each selectin contains an N-
terminal lectin domain, followed by an EGF-like motif, a series of consensus repeats 
similar to those in complement-regulatory proteins, a transmembrane domain and a 
cytoplasmic tail. Each molecule is extensively glycosylated with N-linked 
oligosaccharides (Adapted from (4)). 
 
Regarding the molecular structure, each selectin has an N-terminal carbohydrate 
recognition lectin domain, followed by an EGF domain, a series of consensus repeats, a 
transmembrane domain, and a short cytoplasmic tail (Figure 4.2). P-selectin has 9 
consensus repeats while E- and L-selectin have 6 and 2, respectively. The lectin and EGF 
domains of the three selectins share over 60% identity of the amino acid sequence(50, 
51). The similarities maintain important secondary and tertiary structure features, but the 
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differences are also important, as they allow selectins to recognize subtle but critical 
distinctions in ligands, and thus to differentiate their biological functions. 
It is important to determine which glycoconjugates mediate cell adhesion to 
selectins under physiological flow. All three selectins bind with low affinity to glycans 
with terminal components that include α2,3-linked sialic acid and α1,3-linked fucose, 
typified by the sialyl lewis x (sLe
x
) determinant (Figure 4.3)(5). Sialyl lewis x (sLe
x
) and 
P-selectin glycoprotein ligand-1 (PSGL-1) are important selectin ligands that bind to 
selectins with different affinities. PSGL-1 is the best characterized glycoprotein ligand 
for selectin, which has a transmembrane and homodimeric structure with multiple O-
glycans on its serine and threonine residues (Figure 4.3)(3, 5). Antibody-blocking and 
gene-knockout studies in mice have shown that PSGL-1 is the key leukocyte ligand for P- 






















Figure 4.4: Structure of PSGL-1 and a tetrasaccharide Sialyl Lewis x (sLe
x
). The 
lectin domain of P-selectin makes contact with the PSGL-1 N-terminal containing 
sLe
x
, core-2 O-glycan and a nearby tyrosine sulfate residue. The symbols on the O-
glycans of PSGL-1 represent sialic acid (NeuAc), galactose (Gal), N-
acetylglucosamine (GlcNAc), and fucose (Fuc). (Adapted and modified from (3)) 
 
 
Sialyl Lewis x 
 15
PSGL-1 is a dimmer having two identical subunits that associate non-covalently 
through the transmembrane domains, and form a disulfide bond just outside the 
membrane(54). Each subunit of PSGL-1 is decorated by many O-glycans linked to serine 
and threonine residues. In sharp contrast to most other mucins, PSGL-1 presents only a 
single N-terminal high-affinity binding site for both P- and L-selectin (Figure 4.3). The 
binding site consists of a short peptide sequence that is decorated with a specific core 2 
O-glycan capped with sLe
x
 and with three sulfated tyrosine. Glycan, peptide, and sulfate 
components of PSGL-1 function cooperatively in a stereochemically precise array when 
binding with the lectin domain of P- or L-selectin(55-58). Although the binding site for 
P- and L-selectin is the same on PSGL-1, the binding kinetics and affinity differ 


















Figure 4.5: Model of L-selectin binding with PSGL-1. a, Left, co-crystal structure of 
the P-selectin lectin domain in complex with an N-terminal glycosulfopeptide of 
PSGL-1. Middle, model of the L-selectin lectin domain in complex with PSGL-1. 
Right, model of the L-selectinMut1 lectin domain in complex with PSGL-1. Residue 
Leu8, Leu13, and Pro14 are in the glycosulfopeptide. Residues 108 and 110 are in 
the lectin domains. b, Alignment of the amino acid sequences of the lectin domains 
surrounding residues 108 and 110 (boxed), where substitutions were made to 
generate L-selectinMut1. c, Schematics of glycoconjugates used as selectin ligands. 
The glycosulfopeptide 2-GSP-6 was sequenced based on the N-terminal region of 
PSGL-1. A C-terminal cysteine was introduced to enable coupling of a single biotin 
by a spacer group (not shown). The 6-sulfo-sLe
x
 is a glycan determinant on O-
glycans attached to PNAd. A spacer group links a biotin to the glycan as a molecular 
handle. (Adapted from (28)) 
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Besides PSGL-1, L-selectin also binds to several mucins from lymph node high 
endothelial venules (HEV), collectively called peripheral node addressin (PNAd). 
Sialylation, fucosylation and sulfation are necessary on PNAd molecular for its function 
to bind L-selectin optimally(59). These mucins are decorated with N- and O-glycans 
capped with 6-sulfo-sLe
x
, a form of sLe
x
 with a sulfate ester attached to the C-6 position 
of GlcNAc(28). More detailed structural information is needed to thoroughly understand 
how sulfate, sialic acid, and fucose are optimally coordinated to interact with P- and L-
selectin. Although there are >60% identical amino acid sequences of the lectin domains, 
the molecular basis for differential recognition of specific ligands by the selectins is 
largely unknown. 
P- and L-selectin have been shown to form catch bonds with PSGL-1(11, 12). But 
the molecular mechanism for catch bonds is largely unknown. It is also unclear how the 
force-regulated binding kinetics are affected and modified by the structural components 
in the binding interfaces of selectins and ligands. Using the co-crystal structure of a 
human P-selectin-PSGL-1 complex as template, hints were possibly given for answering 
the above questions based on the model of N-terminal glycosulfopeptide from human 
PSGL-1 docking on the lectin domain of human L-selectin. One notable difference 
between P-selectin and L-selectin complexed with PSGL-1 is that there are more atomic 
level peptide interactions between P-selectin and PSGL-1 than L-selectin. Specifically, 
His108 of P-selectin stacks through hydrophobic contacts against Leu8, Leu13, and 
Pro14 of PSGL-1, while the corresponding Ala108 in L-selectin has a short side chain 
and is not predicted to make similar contacts with PSGL-1. Additionally, in L-selectin, 
steric interference from a bulky His110 side chain might also prevent stacking. Thereby, 
the model predicts that a mutant L-selectin that replaces Ala108 with His, for more 
atomic level interaction, and His110 with Ala (A108H/H110A, or MutI), for less steric 
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hindrance, would interact better with the peptide region of PSGL-1. This L-selectin MutI 
potentially would make L-selectin more like P-selectin in binding with PSGL-1.  
L-selectin binds to the 6-sulfo-sLe
x
 determinant on PNAd but is not known to 
bind directly to the peptide backbones of these heterogeneous glycoproteins. Therefore, 
the model predicts that the amino acid substitutions in L-selectin MutI would alter 
binding to PSGL-1 but not to PNAd. To test the model and hypothesis, we used 2-GSP-6, 
a glycosulfopeptide modeled after the N-terminal region of PSGL-1, and 6-sulfo-sLe
x
 
that recapitulates PNAd as ligands for P- and L-selectin. It is also predicted that 2-GSP-6 
will form catch bonds with WT L-selectin and that the L-selectin MutI would affect the 
catch bond. Similarly, the prediction is that L-selectin MutI would not affect the catch 
bond when binding with 6-sulfo-sLe
x
. Two single point mutants of L-selectin, A108H 
(MutIA) and H110A (MutIB) were both tested to further characterize and complement 


















Binding Specificity Control by Proper Distance 
In our experiment protocol, physical adsorption was used to coat the AFM tip and 
the Petri dish surface with proteins. Wild-type (WT) or mutant L-selectin (MutI, MutIA 
or MutIB) Ig chimera was captured by goat-anti-human Fc IgG (Figure 4.5). The 
capturing antibody was incubated on the Petri dish at 4 
o
C overnight, with the 
concentration of 10µg/ml in PBS. Parafilm was used to seal the Petri dish to keep the 
protein from drying out. On the day of the experiment, the Petri dish was washed three 
times by TSA to remove unadsorbed protein from the surface. Then 5µl of WT/Mutant L-
selectin-Ig (10µg/ml) purified protein was added on the labeled spot for one-hour 
secondary incubation at room temperature. Damp tissue was covered on the Petri dish 




) containing 1% 
bovine serum albumin (BSA without essential IgG), the incubation spots were washed 









Figure 4.6: Experimental set-up of AFM assay to study L-selectin/mutants 




  Cantilever tips were incubated overnight at 4
o
C in 10µg/ml streptavidin (Pierce) 
in PBS. After rinsing by PBS, the streptavidin coated cantilevers were blocked for non-
specific adhesion by 1% BSA in PBS at room temperature for 30 min. The AFM tips 
were used either to test non-specific binding frequency, or for secondary 
functionalization by incubation in 8µl of 500ng/ml biotinylated 2-GSP-6 or 6-sulfo-sLe
x
 










Figure 4.7: Binding frequency dependence on the distances between AFM tip and 
Petri dish surface. Proper distance was used to suppress non-specific binding 
frequency <5% (diamond) while getting ~20% specific binding frequency (square). 
 
We started our experiments by first quantifying the proper distance to suppress 
the non-specific binding while still maintaining high enough specific binding. The 
dependence of the binding frequencies on the distances from the Petri dish surface has 
been characterized for both non-specific binding, wherein a streptavidin coated tip 
(blocked by BSA) interacts with WT/Mutant L-selectin-Ig, and for specific binding, 
wherein a 2-GSP-6/6-sulfo-sLe
x
 coated tip interacts with WT/Mutant L-selectin (Figure 
4.6). The results revealed that the non-specific binding frequencies decreased rapidly 
below 5% when the distance increased to 10 nm. In contrast, the specific binding 
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frequency showed a flatter curve and could still maintain ~15% binding frequency when 
the distance was larger than 10 nm. These results manifest the effectiveness of controlling 
the interaction specificity through distance. Nonspecific interaction is essentially 
electrostatic interaction between two surfaces.  
From these results, we set 13nm as a predetermined distance above the Petri dish 
surface, at which distance the non-specific binding frequency was low enough, but the 
specific binding frequency was much higher, ~20%, such that we could continue for 
single bond lifetime measurements. At the beginning of each experiment, the non-
specific binding frequency would first be tested at 13 nm distance from the surface by 
using the BSA tip to assess the quality of sample preparation, that is, the protein coating 
on the Petri dish. Once we confirmed that non-specific binding was less than 5%, a tip 
functionalized with L-selectin ligands would be loaded for the specific binding test. If the 
specific binding frequency was high enough for lifetime capturing, usually between 15-
30%, the force clamp program would be started to harvest lifetimes. Sometimes 13nm 
would not be enough to suppress non-specific binding below 5%. Then the distance 
would be increased by 1nm increments for the assessment again until satisfied. If the 
distance was too great, such that there was no detectable level of specific binding, we 










Figure 4.8: Specificity test of 2-GSP-6 coated AFM tip binding with wild-type L-
selectin. 
 
Binding specificity was also verified through EDTA wash, DREG56 and PL1 
blocking experiments. Figure 4.7 shows the effect of DREG56 blocking. DREG56 is a 
monoclonal antibody that can block L-selectin’s binding site for 2-GSP-6(12). Compared 
with a streptavidin coated tip, loading a 2-GSP-6 coated tip increased binding frequency, 
evidently because of specific interaction. To confirm that this increase came from the 2-
GSP-6/L-selectin interaction, we added mAb DREG56 (10ug/ml) to the working buffer 
and gently shook for 10 minutes, bringing down the binding frequency to the non-specific 
level, which indicated that L-selectin lost its ability to bind 2-GSP-6. EDTA chelates the 
Ca
2+
 required for L-selectin binding with 2-GSP-6 and 6-sulfo-sLe
x
. Binding frequency 
decreased immediately after addition of 5mM EDTA in the buffer (DPBS with 1% BSA). 
Binding frequency recovered after providing Ca
2+




) buffer in the system (data not shown). PL1 is a monoclonal antibody targeted 
for 2-GSP-6 and inhibits its binding with L-selectin. The observation was similar to 
DREG56 and EDTA’s effect, and thereby confirmed the binding specificity (data not 
shown). 
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As force increases wild-type L-selectin forms catch bonds and then slip bonds with 
2-GSP-6 and 6-sulfo-sLe
x














Figure 4.9: Mean bond lifetime measurement vs. force for WT/MutI L-selectin 
interacting with 2-GSP-6. MutI L-selectin eliminates the catch bonds at low forces 
regime. 
 
Figure 4.8 shows the lifetime comparison of WT/MutI L-selectin binding with 2-
GSP-6, confirming that WT L-selectin forms catch bonds with 2-GSP-6, while binding 
with PSGL-1. The lifetime peaks at ~37pN and gives ~0.17 seconds lifetime. This peak 
lifetime value is comparable to that of the L-selectin-PSGL-1 bond but with lower peak 
force(12). After the peak, the bonds’ lifetimes decrease with increasing force, exhibiting 
slip bond behavior. In sharp contrast, MutI L-selectin totally eliminates the catch bond 
regime, giving monotonously decreasing lifetimes with increasing forces. The slip bond 
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regime collapses with that of WT L-selectin. The elimination of catch bonds by MutI 























Figure 4.10: Mean bond lifetime measurement vs. force for MutIA/MutIB L-selectin 
interacting with 2-GSP-6, compared with WT L-selectin data from Figure 4.8 
(square). MutIA (A108H) L-selectin (circle) eliminates catch bonds at low forces 
regime as MutI; MutIB (H110A) L-selectin (triangle) quantitatively shifts the catch-
slip bond as MutII (N138G). (30) 
 
After studying MutI, we continued to test the two point mutants: MutIA (A108H) 
and MutIB (H110A) to further characterize the mutant effects (Figure 4.9). Interestingly, 
MutIA exhibits behavior similar to MutI in that it also eliminates the catch bond regime 
at low force, with monotonously decreasing lifetimes with increasing forces. MutIB 
showed enhanced catch bonds at low force, giving longer lifetimes at the catch bonds 
regime than the WT L-selectin. Lifetimes peak at ~0.3 seconds and shift toward lower 
force (~30pN). When forces are larger than 30pN, the bonds transit to slip bonds with 
decreasing lifetimes until approximating the slip bond curve of WT L-selectin. 
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WT L-selectin forms catch-slip bonds with 6-sulfo-sLe
x
, L-selectin mutants MutI, 
MutIA and MutIB have no effects on bond lifetimes with 6-sulfo-sLe
x
 
After characterizing WT L-selectin and mutant effects on their binding kinetics 
with PSGL-1 surrogate 2-GSP-6, we further tested whether amino acid residue 
replacements on the peptide backbone affect L-selectin’s binding with PNAd surrogate 6-
sulfo-sLe
x
. Figure 4.10 illustrates the lifetime measurements of WT L-selectin interacting 
with 6-sulfo-sLe
x
, in comparison with two mutants A108H and H110A. 
In marked contrast to the lifetime data of L-selectin interacting with 2-GSP-6 
(Figure 4.9), interactions between L-selectin and 6-sulfo-sLe
x
 also exhibit catch-slip 
transitional bonds as force increases. Neither MutIA nor MutIB changed the WT L-
selectin’s catch-slip transitional bonds with 6-sulfo-sLe
x
, confirming our hypothesis that 
the amino acid residue substitutions in L-selectin alter the force dependent kinetics of L-
selectin bonds in a ligand-specific manner as predicted by the structure model. That is, 
the A108H and H110A mutations are located at the 2-GSP-6 binding interface but not in 
direct atomic level interactions with 6-sulfo-sLe
x
; therefore these two point mutations 







































Figure 4.11: Mean bond lifetime vs. force measurements for MutIA/MutIB L-
selectin interacting with 6-sulfo-sLe
x
, compared with WT L-selectin data (square). 
MutIA (A108H, circle) and MutIB (H110A, triangle) mutants haven’t changed the 






The mean bond lifetime measurements obtained by using AFM are in good 
agreement with the flow chamber experimental data (Figure 4.11). In the flow chamber 
experiments, microspheres were coated with selectin-Ig chimeras captured by anti-human 
Fc antibody and perfused at various shear rates (thus different wall shear stresses) over 
low densities of 2-GSP-6 or 6-sulfo-sLe
x
 captured by streptavidin on the flow chamber 










Figure 4.12: WT and MutIA L-selectin tether lifetime measurements by flow 
chamber experiments, showing single-residue substitution in L-selectinA108H 
converts catch bonds to slip bonds with 2-GSP-6 (left panel) but not with 6-sulfo-
sLe
x
 (right panel). (Adapted from (28)) 
 
Previous studies have demonstrated that the rolling of L-selectin-bearing 
microspheres or cells on PSGL-1 below optimal shear was governed by catch bonds, 
whereas rolling above optimal shear was governed by slip bonds(15). To determine 
whether eliminating catch bonds affects the shear threshold requirement for L-selectin-
dependent rolling, microspheres bearing L-selectin were perfused over higher densities of 
2-GSP-6 or 6-sulfo-sLe
x
. Rolling motions were recorded and analyzed based on high-
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speed video microscopy as a function of wall shear stress. The results show that the 
amino acid substitutions of L-selectin as in MutI and MutIA eliminate the shear threshold 
for rolling on 2-GSP-6 but not on 6-sulfo-sLe
x
, and further document that catch bonds 
govern flow-enhanced neutrophil adhesion through L-selectin(28). 
It has not been explained why circulating leukocytes do not aggregate with each 
other even though they express both L-selectin and its ligand PSGL-1. One possible 
explanation is that the bonds formed between randomly colliding leukocytes through L-
selectin/PSGL-1 interaction have lifetimes at small forces (the relative velocity between 
circulating leukocytes is low) that are too short for stable adhesion because of catch bond 
formation. To test this hypothesis, neutrophils or mixtures of neutrophils and 
microspheres bearing L-selectin were flown in a shear field to promote collisions at a 
wall shear stress of 1 dyn/cm
2
. To quantify the aggregation effects, mixtures of 
neutrophils (labeled with red dye PKH26) and microspheres (labeled with green dye 
FITC) were perfused and fixed after they exited the flow chamber. Flow cytometry and 
fluorescence microscopy revealed very few particles containing fluorescence markers for 
both neutrophils and L-selectin microspheres. However, it showed many particles labeled 
for both neutrophils and L-selectin MutI/MutIA microspheres, confirming that aggregates 
developed through engagement of L-selectin MutI/MutIA (Yago et al., unpublished 
data). These data suggest that these two mutants prolong lifetimes by eliminating catch 
bonds between PSGL-1 and L-selectin and that they cause aggregation of flowing 
leukocytes. The catch bond mechanism shortens lifetimes under small forces that link cell 
aggregates but lengthens lifetimes under large forces that act on those bonds that support 
cell rolling. Therefore, this mechanism would allow leukocyte rolling on vascular 
surfaces but not aggregation of circulating leukocytes. 
The prolonged lifetimes of MutI/MutIA L-selectin with 2-GSP-6 at very low 
forces suggest that the “better stacking” mutant A108H provides additional atomic level 
interactions to peptide components of PSGL-1 such that the binding is stronger than WT 
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L-selectin at lower forces. The molecular mechanism of the catch bonds between WT L-
selectin and PSGL-1 still requires further study. One possible explanation for the 
elimination of the catch bond is that the replacement of Ala by His at 108 changes the 
possible path during dissociation along the binding interface. 
The similarities between MutI and MutIA interacting with 2-GSP-6 and 6-sulfo-
sLe
x
 indicate that A108H substitution causes the elimination of catch bonds; this was also 
confirmed by H110A data showing a catch bond that was shifted instead of being 
eliminated. MutIB exhibits augmented catch bonds with longer lifetimes at smaller 
forces, which is similar to the L-selectin MutII N138G(30). Unlike the allosteric mutation 
at the hinge linking the L-selectin EGF domain and the lectin domain, H110A is located 
at the direct binding interface of the receptor-ligand. Therefore, it is more likely that the 
decreased steric hindrance would allow more new interactions during forced dissociation 
along the binding interface. Again, because this change will most likely affect the peptide 
interaction, the binding kinetics with 6-sulfo-sLe
x
 are not affected, as is confirmed by the 
lifetime data. 
It is interesting to find WT, MutIA and MutIB L-selectin form similar catch bonds 
with 6-sulfo-sLe
x
. There must be another mechanism by which force enhances interacts 
with this ligand, which has no peptide components. The interaction of L-selectin and its 
mutants binding with 6-sulfo-sLe
x
 includes hydrogen bonds and ionic bonds involved in 
the calcium coordination. Each individual bond could be derived as following the Bell 
model(17). In this regard, the sliding-rebinding model could also be applied, thus 
generating the catch bonds(60). 
The residue substitutions A108H and H110A of L-selectin were designed to make 
it more like P-selectin when interacting with PSGL-1. Although much longer lifetimes 
were obtained from elimination of catch bonds at low forces, MutI and MutIA exhibit no 
detectable catch bonds with PSGL-1, while P-selectin displays catch-slip transitional 
bonds with PSGL-1 and has even longer bond lifetimes at all forces. These data suggest 
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that other differences between P- and L-selectin also contribute to the off-rate 
differences. These factors could be allosteric regulation, as discussed previously(30). 
These results offer insights into the structural basis for the catch bonds, and they show 
how force affects interaction kinetics among adhesion molecules. 
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CHAPTER 5 
BINDING KINETICS OF GPIBΑ WITH VWF 
 
Introduction 
The primary function of hemostasis is to stop bleeding at sites of injury. Platelets’ 
adhesive functions are necessary to limit blood loss at sites of vascular injury, including 
areas of the circulatory system with the highest levels of shear stress(7). Moreover, 
platelets are of vital importance in the process of acute occlusion of atherosclerotic 
arteries, ischemia-reperfusion injury, deep venous thrombosis, and inherited bleeding 
disorders(61-66). The formation of a platelet plug to staunch blood leaking from an 

















The binding of platelet glycoprotein (GP) Ib-IX-V to its ligand immobilized on 
the exposed subendothelium surface, the von Willebrand factor (VWF), initiates the first 
step of hemostasis by recruiting patrolling platelets in the blood to the damaged vascular 
surface and also initiates the thrombi formation that underlies cardiovascular heart 
diseases and stroke (7). Glycoprotein Ibα (GPIbα) is the central component of the 
receptor complex expressed on the platelets’ surface; it contains eight tandem leucine-
rich repeats (LRRs) that wrap around one side of the von Willebrand Factor (VWF) A1 

















Figure 5.14: Schematics of GPIb-IX-V complex structure (adapted from (69)), and 









VWF, synthesized in megakaryocytes and endothelial cells as pre-pro-VWF, 
undergoes an extensive posttranslational process of cleavage, glycosylation, sulfation, 
multimerization and sorting in the endoplasmic reticulum, the Golgi apparatus and the 
trans Golgi network (70, 71). VWF is partitioned through two pathways, ~95% 
constitutively secreted and the rest stored in the tubular structures in the α-granules of 
megakaryocytes and in the Weibel-Palade bodies of endothelial cells, which release it 
upon activation (72, 73). After being released into the plasma, adhesive ultralarge VWF 
(ULVWF) multimers are cleaved by metalloprotease ADAMTS-13 at A2 domain into 
smaller circulating pieces which are less adhesive under normal shear (74, 75). 
For binding with GP Ibα, VWF-A1 needs to be activated through high fluid shear, 
modulators (such as snake venom ristocetin or botrocetin), or through immobilization to 
extracellular matrix proteins (such as collagen) (76). Type 2B VWD mutations can also 
activate VWF-A1, possibly through changing the molecular conformation (76). There are 
three types of VWD resulting from qualitative or quantitative deficiency in VWF: type 1, 
2 and 3 VWD. Type I refers to a partial quantitative deficiency of VWF; Type II is 
related to a qualitative VWF deficiency; while type III refers to total deficiency of VWF. 
Type II VWD can be further divided into four subtypes: Type 2A is characterized by the 
absence of a normal amount of ULVWF that leads to decreased platelet-dependent 
function; Type 2B VWD has been characterized in terms of a gain-of-function phenotype 
with increased affinity for GPIbα and removal of ULVWF from the circulation (77); 
Type 2M VWD patients have normal ULVWF counts but have decreased GPIbα binding 
affinity, thus these are so-called loss-of-function mutations; Type 2N refers to VWF with 
decreased affinity for factor VIII.  
At least fourteen mutations, located mostly inside a disulfide loop C509-C695 of 
VWF-A1, have been found associated with type 2B VWD (78-80). From the secondary 
structure, these mutations are scattered throughout the A1 domain and its N- and C-
terminal flanking peptides. While in the 3D crystal structure, these mutations cluster at 
 34
the bottom of the domain (Figure 5.2). Furthermore, type 2B mutations have been 
reported to induce the A1 conformational change at the GPIbα binding interface (81). 
The molecular mechanism for gain-of-function is not clear yet. In contrast, type 2M 
mutations scatter all over the 3D crystal structure of the A1 domain, with some mutations 
buried inside the Rasman fold but still essential for the A1 conformation. It is 
hypothesized that these mutants would result in a mis-folded structure for the A1 domain, 
thus affecting binding with GPIbα. 
What makes the hemostatic and thrombotic processes remarkable is that platelets 
adhere and aggregate under dynamic conditions of blood flow, which transports platelets, 
and against hydrodynamic forces, which push platelets away. As key regulators, flow and 
force impact these processes in multiple ways (82). Circulating plasma VWF does not 
agglutinate flowing platelets under physiological conditions, but it does so when exposed 
to pathologically high shear flow (such as found in areas of stenosed arteries) in a process 
called shear-induced platelet aggregation (76). Platelets tether to, and roll on, 
immobilized VWF, but do not firmly adhere under arterial flow (83). Flow enhances 
rather than impedes platelet adhesion, despite the dislodging forces (7). Platelets usually 
do not tether at low flow, and rolling platelets detach if arterial flow is reduced (38, 84). 
Although counter-intuitive, these VWF-mediated adhesion properties may be biologically 
important. Disease-related mutations in VWF have been found to change the mechanical 
regulation of platelet adhesion. For example, a single-residue type 2B mutant I1309V in 
the VWF A1 domain (85) lowers the shear requirement for binding (38, 84). 
The similarities between selectins and GP Ibα-VWF in promoting and sustaining 
cell adhesion in flow suggest that their receptor-ligand bond kinetic properties may also 
be similar. Kinetic studies have demonstrated a high rate of bond formation and 
dissociation between GPIbα and VWF-A1 (38, 68, 84, 86). The slow intrinsic binding 
kinetics of the GPIbα-VWF-A1 bond have also been reported to mediate rapid platelet 
adhesion (87). Using AFM and transient tether lifetime measurements in the flow 
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chamber, the catch bond has been revealed to govern the flow enhancement of L-selectin 
mediated leukocytes adhesion (15). Here we demonstrated that flow-dependent platelet 
adhesion is subject to catch-slip-transitional bonds, and that the mechanism of "gain-of-
function" is due to slow off rate at low force. From the single molecular kinetics 




Binding Specificity Control by Proper Distance 
To test our hypothesis that a catch bond exists for the GPIbα-A1 interaction, we 
started by measuring the bond lifetime. To measure a specific interaction, the non-
specific binding frequency needs to be controlled at a low enough level. Because we 
control the protein coating density to maintain the specific binding frequency at around 
20% (mostly single bond based on Poission distribution), it is of equal importance to 
ascertain that non-specific binding is below 5%. As we did for controlling specificity of 
L-selectin/PSGL-1 binding, the distance between receptor/ligand coated surfaces was 
monitored to give optimal results.  
As shown in Figure 5.3 below, we coated the Petri dish surface using 10ug/ml A1 
protein. 10ul of protein in PBS buffer was coated on two labeled spots (blue spots in the 
figure) and kept overnight in a 4
o
C refrigerator. On the day of the experiment, the coating 
spots were washed three times by PBS to remove excessive protein. Then 5ml 1% BSA 
in PBS was filled in the Petri dish to block non-specific binding, mainly from 
electrostatic interaction between bare surfaces. The AFM tip was coated by 10ug/ml 
glycocalicin (extracellular domain of GPIbα) overnight at 4
o
C. Another tip was coated by 
1% BSA in PBS solution as a control. On the day of the experiment, a glycocalicin 
coated (specific) tip was soaked in 1% BSA (in PBS) solution to block non-specific 
binding. Although small molecule BSA would cover most bare surfaces, there might still 
be non-specific binding from electrostatic or hydrophobic interactions between two 
opposing surfaces. To decrease the percentage and impact of such non-specific binding in 
our experiments, we separated further the AFM tip from the Petri dish to minimize their 
non-specific interaction. Therefore, before we measured the specific interaction, we 
quantified how increasing the distance between two surfaces would lower non-specific 
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and specific binding frequencies and whether we could find the proper distance at which 
to harvest specific binding data with minimum non-specific binding. As shown in Figure 
5.3, three points were tested on either spot labeled on the Petri dish. Binding frequencies 
were counted for each point at various distances from the Petri dish surface. For each 
point, we built a binding frequency vs. distance curve. From these three points, an 









Figure 5.15: Diagram showing the experiment setup for physical adsorbed A1 
protein on Petri dish and glycocalicin on AFM tip, distance d is controlled to 
suppress the non-specific interaction but still with enough specific binding 
frequency. 
 
Both non-specific (BSA/A1) and specific (glycocalicin/A1) interactions were 
tested for the distance effects on binding frequency. Data show both the non-specific and 
specific binding frequency decreased with increasing distance of the AFM tip from the 
Petri dish surface. Distance is calculated from the piezo position of “500ms holding 
phase” subtracting the “zero distance” position. The “Zero distance” piezo position 
corresponds to the starting bending point at which the AFM tip and the cantilever just 
begin to push down on the Petri dish (Figure 5.4). A negative distance measurement 
means the AFM tip was still in contact with the surface and there was a downward 
bending of the cantilever causing an indent force on the Petri dish surface. 
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“500ms holding” 



















Figure 5.16: Distance calculation from A-B signal time trace. The piezo was 
retracted to a preset distance and held for 500ms (“500ms holding” phase, green 
arrows) before further retraction, to test whether there was any adhesion. The AFM 
tip contact point with the Petri dish was determined by the A-B signal’s sudden 
decrease (red arrow), where “zero distance” position was used to determine AFM 



















Figure 5.17: With the distance increase of AFM tip from Petri dish, the decrease of 
specific binding (A1-R543Q/GPIb interaction) frequency is slower than the decrease 
of non-specific binding (BSA/GPIb) frequency. Therefore, we take 4nm as starting 
distance to suppress non-specific binding while still can harvest specific binding. 
WT and R687E mutant A1 shows similar behavior. 
 
Using the above method to quantify the non-specific binding frequency, the 
assumption is that if three points from one coated spot gave less than 5% binding 
frequency consecutively, then the spot would be deemed to have low enough non-specific 
binding. We found that coating concentration and protein length had very obvious effects 
in affecting the non-specific binding, that is, higher coating concentration would lead to 
higher non-specific binding frequency, and would need a longer distance to suppress; 
longer protein would also need longer suppressing distance. From Figure 5.5, we can also 
observe the much slower decrease of specific binding frequency compared with non-
specific binding frequency. Non-specific interaction mainly came from the electrostatic 
and van der Waals interaction between the Petri dish surface and the AFM tip. This 
interaction is highly dependent on distance, as the van der Waals force has 10
-6
 
dependence on distance. Coulomb’s law gives a 10
-2
 dependence of attraction force on 
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distance between two opposite charges. In contrast, glycocalicin coated AFM tips would 
have longer range of effective binding distance because the molecules could assume 
different orientation and conformation in the buffer. On the other hand, glycocalicin 
molecules had much longer molecular lengths than BSA; this feature further increased 
the effective binding range. For our experiments, we could only control the distance 
between the AFM tip and the Petri dish surface. The goal is to diminish the electrostatic 
interaction between the AFM tip and the Petri dish because we believe that is the major 
reason for non-specific interaction. In our assumption, the possibility of glycocalicin 
binding to the Petri dish surface or A1A2A3 binding with an AFM tip (silicon nitride) is 
minimal. 
Because the non-specific binding frequency was lower than 5% at 4nm distance, 
we would use 4nm distance as the starting value for every experiment. If the spot could 
give three consecutive points with less than 5% non-specific binding frequency in 50 
contacts, we would assume the coating spot to be good enough for the subsequent 
specific measurement. Otherwise, we would increase the distance to decrease the non-
specific binding until we found an appropriate distance. In some cases, the distance value 
























Figure 5.18: VWF-A1 mAb 5D2 blocks GPIb binding with WT, R687E and R543Q 
mutants. (5D2 was generous gift from Dr Robert Andrews of Monash University) 
 
Besides distance control, we also tested the binding specificity by using antibody 
5D2. The monoclonal antibody 5D2 is of the IgG1 subtype; it has been characterized as 
anti-VWF-A1 antibody that can strongly inhibit both ristocetin- and botrocetin-dependent 
binding (76, 88). For a control experiment, we tested the binding frequency of a BSA-
coated AFM tip and glycocalicin-coated tip with VWF-A1 coated Petri dish surface. We 
added 25ug/ml 5D2 into buffer and the Petri dish was put on a lab rocker for 10 minutes’ 
mixing to block VWF-A1. The glycocalicin coated AFM tip would then be applied to test 
the binding frequency again. As shown in Figure 5.6, glycocalicin coated AFM tips had 
much higher binding frequency than BSA coated tips. After adding the VWF-A1 
blocking mAb, 5D2 inhibited all the binding between WT/R687E/R543Q and 
glycocalicin. 
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Figure 5.19: Scatter plot of over 800 lifetime measurements for GPIbα interacting 
with wild-type VWF-A1. 
 
After confirming the binding specificity, we continued to use the force clamp 
routine to harvest lifetimes (Figure 5.7). The lifetimes of GPIbα/A1 bonds were measured 
in thousands of repeated test cycles. Each cycle consisted of moving the cantilever tip to 
touch the Petri dish for 0.02 s, retracting it ~4 nm above the surface and holding it for 1 s 
to allow for bond formation. It is then further retracted to a predetermined distance to see 
if binding occurs, and, if so, to determine if the bond survives ramping to the preset force 
and if it does, to measure how long the bond lasts at that force (i.e., bond lifetime). At the 
end of this process, the cantilever tip is finally retracted to the starting position. 
Suspending the cantilever tip ~4 nm above the surface in the bond formation phase 
 43
usually reduced nonspecific binding to <5% of the test cycles, whereas specific GPIb/A1 
binding occurred at ~20% of the test cycles. A large number of mostly single-bond 
lifetimes were measured to derive the mean lifetime (which equals the reciprocal off-rate 













Figure 5.20: Mean bond lifetime vs. force data shows GPIbα forms catch-slip 
transitional bonds with WT VWF A1 as force increases. 
 
Figure 5.8 shows the analysis results based on a different force bin. Interestingly, 
it shows a catch-slip transitional bond. The lifetimes of GPIbα/A1 bonds exhibited a 
biphasic pattern characteristic of transition from catch to slip bonds. The mean lifetime 
increased with increasing force, indicating the presence of catch bonds, until an optimal 
force ~23pN was reached where the lifetime reached a maximum value at around 0.3 
seconds. Thereafter, the mean lifetime decreased with increasing force, indicating the 
presence of slip bonds. To confirm this catch bond behavior, we zoomed in using the low 
force range and did a strict examination of the bond lifetime, as shown in Figure 5.9. The 
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upper panel shows the scatter plot of lifetime raw data in different colors, representing 
different force bins. The continuity in distribution of lifetimes in each force bin suggested 
that the data was not biased by different populations. The ln[(# of measurements with a 
lifetime > t)/(total number of measurements)] in each force bin analysis also exhibited a 
decrease in –slope value with increasing force, suggesting the off-rate decrease with 
increasing force. Combined with the catch bond observation for selectin/PSGL-1 system, 
GPIbα/A1 is the second molecular system showing catch bond observation (29). As to P- 
and L-selectin/PSGL-1, the catch bond has been shown to help recruit leukocytes to the 
inflammation site; the L-selectin/PSGL-1 catch bond also helps prevent inappropriate 
aggregation of leukocytes. The GPIbα/A1 catch bond has been shown to be the molecular 























Figure 5.21: Scattergrams in the five force bins which were used to obtain the five 
average lifetime vs. average force data in the catch bond regime shown in Figure 
5.8, and lifetime distributions, i.e., ln[(# of measurements with a lifetime > t)/(total 
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 46
After observing the catch bond for GPIbα/WT-A1 interaction, we continued 
measuring the lifetime for gain-of-function (GOF) A1 mutants R687E (or R687E) and 
R543Q (or R543Q). These two A1 mutants have been shown to be related to type 2B von 
Willebrand disease (VWD). The R543Q mutant naturally occurs in patients with type 2B 
VWD(89). Mutant R687E was designed to mimic the gain-of-function phenotype of type 
2B VWD. GPIbα is thought to bind with higher affinity to these gain-of-function mutants 
of A1 than to WT A1. Figure 5.10 shows the mean bond lifetime vs. force curve for 














Figure 5.22: Mean bond lifetime vs. force for R543Q A1 mutant interacting with 
GPIbα. Error bars are standard error of the mean. 
 
In sharp contrast to the catch-slip bond observed for WT-A1 interacting with 
GPIbα, R543Q totally eliminated the catch bond and only showed a monotonous decrease 
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of mean bond lifetime in the whole force range, indicating a slip bond behavior. The 
elimination of catch bonds resulted in longer bond lifetime at low force regime. At about 
5pN, R543Q’s mean bond lifetime was over 0.3 seconds, while WT-A1 gave only about 
0.1 second bond lifetime, with possible extrapolation toward even lower force. With the 
continuous decrease, R543Q had lower bond lifetime than WT-A1 when the force value 
exceeded ~15pN. The difference between the two curves was maximal at the peak of 
WT-A1, giving a comparison of 0.75 seconds vs. 0.3 seconds for R543Q and WT-A1, 
respectively. This difference diminished when force kept increasing until finally the two 
curves collapsed after ~60pN. For R543Q, the three-fold higher lifetime at low force may 
explain the enhanced adhesion between platelets/GPIbα coated microspheres with A1 
coated parallel plate flow chamber wall(29). 
To confirm our observation of this elimination of catch bond for R543Q A1 
mutant, we strictly scrutinized the low force lifetime measurements and compared with 
WT-A1 data, as shown in Figure 5.11. The scattergram shows a continuous decrease of 
value distribution, which forms a sharp contrast to the continuous value increase in the 
distribution of WT-A1/GPIbα lifetime value. The ln[(# of measurements with a lifetime > 
t)/(total number of measurements)] in each force bin analysis also exhibited an increase 
in –slope value with increasing force, suggesting an off-rate increase with increasing 
force, typical of slip bond behavior. The change in –slope value was not as obvious as for 





























Figure 5.23: Scattergram of low force lifetime measurements used to obtain the 
three average lifetime vs. average force data shown in Figure 5.8, and lifetime 
distributions, i.e., ln[(# of measurements with a lifetime > t)/(total number of 
measurements)] in each force bin measured by AFM. 
 
 49
An interesting observation for the analysis of ln[(# of measurements with a 
lifetime > t)/(total number of measurements)] in each force bin is that the data points 
were not aligned very well with the fitted line, suggesting there could be other factors 
contributing to these effects. Binding pocket difference for GPIbα/A1 could be one 
possibility. It has been reported that A1 could adopt different conformational states. For 
our physical adsorption protocol, A1 could have already been activated. But chances are 
that part of the molecule population remained inactive. Furthermore, A1 could also be 
partially/wholly unfolded, based on previous studies (60). The repeated stretching of A1 
by GPIbα could be the cause of partial/complete unfolding, thus affecting the 
conformation upon bond breaking. It has also been reported that the type 2B mutation 
could result in a different conformation of the A1 molecule (67, 68). This way, the 
binding interface of GPIbα/A1 could be different for WT-A1 and R543Q mutants, 
leading to the observed difference in bond kinetics behavior. 
If the R543Q A1 mutant showed elimination of the WT-A1 catch bond, another 
GOF mutant R687E could also eliminate the catch bond. To test this hypothesis, we 
measured the bond lifetime of GPIbα/R687E, as shown in Figure 5.12. Similar to the 
R543Q mutant, the R687E mutant also showed a monotonous decrease in mean bond 
lifetime with increasing force, or slip bond behavior. We harvested more large value 
lifetimes under the low force regime, prolonging the mean bond lifetime even longer than 
was the case for the R543Q mutant. Except for the difference at the catch bond regime, 
R687E collapsed with WT-A1 data at the slip bond regime. The observation of sharp 
decrease in lifetime at low force regime was repeated for the scattergram, and slopes of 
ln[(# of measurements with a lifetime > t)/(total number of measurements)] were 

















Figure 5.24: Mean bond lifetime vs. force for R687E A1 mutant (circle) interacting 
with GPIbα, in comparison with WT-A1 data (solid diamond). Error bars are 
standard error of the mean. 
  
Compared with the R543Q data analysis in Figure 5.11, R687E gave a clearer 
trend in the off-rate (-slope) increase in the four force bins. There were still slope 
transitions in the ln[(# of measurements with a lifetime > t)/(total number of 
measurements)] analysis, but these were not as obvious as those in R543Q. The 
observation of longer lifetime for the R687E mutant than for R543Q at low force is 
consistent with the previous studies showing that R687E had more evident “gain of 
function” in the “shear induced platelet aggregation” (SIPA) and “ristocetin induced 
platelets aggregation” (RIPA) assays. This change in binding kinetics may come from 
























Figure 5.25: Scattergram of low force lifetime measurements used to obtain the four 
average lifetime vs. average force data shown in Figure 5.12, and lifetime 
distributions, i.e., ln[(# of measurements with a lifetime > t)/(total number of 






Discussion (adapted and modified from (29)) 
“The above findings of force regulated binding kinetics for WT and two GOF 
mutants A1 interacting with GPIbα were complemented by flow chamber studies and 
SMD simulation. In summary, flow chamber data showed that catch bonds caused 
platelets and GPIbα-coated microspheres to roll slower on VWF or WT A1 as flow 
increased below suboptimal shear; this explains flow-enhanced rolling. Longer bond 
lifetimes at low forces eliminated the flow requirement for rolling on R543Q and R687E 
A1(29). Flowing platelets agglutinated with microspheres bearing R543Q or R687E A1 
or A1A2A3-triplets but not with WT A1 or A1A2A3. Therefore, catch bonds may 
prevent VWF multimers from agglutinating platelets. Steered molecular dynamics 
simulations of GPIbα dissociating from A1 suggested mechanisms for catch bonds that 
A1 mutations lack(29).  
These findings demonstrate how force regulates platelet rolling on VWF, 
illustrate its similarity to force regulation of leukocyte rolling through selectins, suggest a 
structural basis for this regulation, and offer insights into the molecular basis for type 2B 
VWD. 
 The counterintuitive “arterial flows enhanced platelet adhesion to VWF” was 
noted over a decade ago but was not explained (7, 38, 84). The flow chamber study 
demonstrates how flow strengthens rolling adhesion through slower and more regular 
rolling steps (Figures 1, 3, and 4 of (29)), which are governed by the off-rate of 
dissociation of GPIbα/VWF bonds. By measuring the force-dependent lifetimes of single 
bonds or tethers between purified or platelet-expressed GPIbα and the VWF A1 domain 
at forces lower than those previously studied, we directly demonstrated transitions from 
catch bonds to slip bonds by using the AFM data and flow chamber tether lifetime data. 
Previous studies only observed slip bonds at higher forces. Second, by scaling the 
analysis of platelets and GPIbα-bearing microsphere rolling on intact VWF or VWF A1 
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domain ((29) Figures 1, 3, and 4), we showed that force-dependent dissociation kinetics 
of GPIbα/VWF interactions governed rolling velocity and that catch bonds specifically 
governed flow-enhanced rolling, i.e., the ability to roll more slowly and more regularly as 
flow increases from a suboptimal rate. As flow increased above the optimal rate, catch 
bonds transitioned to slip bonds and rolling velocities increased. The interactions of P-
selectin and L-selectin with their glycosylated ligands also transition from catch to slip 
bonds as force increases, and catch bonds govern flow-enhanced leukocyte rolling 
through L-selectin. Thus, two structurally distinct receptor/ligand systems use catch 
bonds to enable flow-enhanced rolling of blood cells on vascular surfaces. 
 Besides, two single-residue substitutions in the VWF A1 domain, R543Q and 
R687E, were used to further explore the force regulation of GPIbα/VWF interactions. 
Both VWF mutants exhibit features of type 2B VWD and both have increased affinity for 
GPIbα in the absence of force. Extending this result, we observed that bond lifetimes of 
both A1 mutants with GPIbα were longer at low forces, eliminating catch bonds and 
resulting in a monotonic shortening of bond lifetimes (slip bonds) as force increased. 
These mutations eliminated the shear threshold requirement for platelet or GPIbα-bearing 
microsphere rolling on VWF and strengthened the causal relationship between rolling 
velocity and the dissociation kinetics of GPIbα/VWF bonds. Single-residue substitutions 
in the hinge between the lectin and EGF domains of L-selectin (30) or in the ligand-
binding surface of L-selectin (90) similarly prolong bond lifetimes at low forces and 
reduce (30) or eliminate (90) the shear threshold for leukocyte rolling. Catch bonds 
provide a mechanism to support platelet rolling on VWF immobilized on surfaces but to 
prevent inappropriate agglutination of circulating platelets by binding to VWF multimers 
in plasma. Consistent with this notion, flowing platelets agglutinated with microspheres 
bearing R543Q or R687E A1 or R687 A1A2A3 but not with WT A1 or WT A1A2A3. 
Similarly, flowing leukocytes, which express the L-selectin ligand PSGL-1, do not 
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agglutinate with microspheres bearing WT L-selectin but do agglutinate with 
microspheres bearing L-selectin mutants that prolong lifetimes at low forces (30). Thus, 
catch bonds may provide a general mechanism for blood cells to adhere to vascular 
surfaces but not to agglutinate as they circulate.  
Crystal structures of GPIbα/VWF A1 complexes have provided important 
information on the molecular details of the interactions, but they do not indicate how the 
complexes respond to applied force and they have not readily explained how type 2B 
VWD mutations in the A1 domain clustered outside the binding site can alter function. 
The SMD simulations of dissociation of the WT GPIbαN:A1 complex enabled us to 
visualize dynamic conformations not seen in the equilibrium conformations of the crystal 
structures, to determine how force regulates these conformational changes, and to assess 
how such changes might elicit catch bonds. These simulations suggest that force breaks 
interactions of D1269 with R543 or R687 in the A1 domain, causing A1 to rotate and 
slide along the interface with GPIbα. The sliding allows R1334 in A1 to form a strong 
salt bridge with E14 in GPIbα that delays dissociation of the molecular complex after all 
atomic-level interactions seen in the crystal structure have disrupted. This provides a 
structural mechanism for the experimentally observed catch bonds. Remarkably, the 
sliding-rebinding mechanism resembles that observed in SMD simulations of P-selectin 
dissociating from its ligand PSGL-1, where force breaks interactions at the lectin-EGF 
domain interface, causing the lectin domain to rotate and to form new interactions as it 
slides along the interface with PSGL-1(91). A mutation that disrupts an interaction 
between the lectin and EGF domains of L-selectin reduces the force required to rotate the 
lectin domain and to slide along the interface with its ligands (30).  
Free dynamics and SMD simulations of dissociation of the mutant GPIbαN:A1 
complex have provided explanations for the gain-of-function phenotype and the 
elimination of catch bonds by the R543Q mutation; this may also explain the effects of 
 55
the R687E mutation. In the model, the mutation results in formation of the E14:R1334 
salt bridge at zero force and no new contacts after force is applied. An alternative model 
similar to one previously proposed (30) suggests that the R687E mutation removes the 
interaction with D1269, which allows the sliding-rebinding mechanism to allosterically 
prolong lifetimes at nearly zero forces. The same mechanism can explain the gain-of-
function phenotype of the H1268A/D1269A A1 mutant (92), because the D1269A 















Figure 5.26: At the same shear rate, tensile force applied to bonds that link flowing 
platelets or microspheres is much lower than that applied to bonds that tether 
rolling platelets or microspheres. The schematics show tensile forces between two 
spheres of equal or unequal sizes in a doublet or between a sphere and the wall 
under a simple shear field. 
 
Our data provide a biophysical mechanism for the phenotypes of patients with 
type 2B VWD. The platelet-binding activity of VWF increases with the size of the 
multimers, which may assume different conformations to expose binding sites for GPIbα 
on A1 domains (93, 94). In thrombotic thrombocytopenic purpura, ultralarge multimers 
may be particularly capable of exposing very large numbers of binding sites on A1 
domains that spontaneously agglutinate circulating platelets (95). However, the number 
of exposed binding sites in plasma VWF multimers of normal size cannot stably 
agglutinate platelets because the lifetimes of A1 bonds with GPIbα are too short at 
arterial shear rates (500 to 5,000 s
-1
). Shear-induced platelet aggregation only occurs at 
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the very high shear rates, e.g. 20,000 s
-1
, found in stenotic arteries (96, 97). At these shear 
rates, the forces applied to platelet doublets linked by VWF multimers are sufficiently 
large to elicit catch bonds (see Figure 5.14), which prolong bond lifetimes enough to 
agglutinate circulating platelets. Extremely high shear rates may also expose more 
binding sites for GPIbα on A1 domains of normal-sized multimers (96, 97). In type 2B 
VWD, the longer lifetimes of VWF with GPIbα at low forces enable plasma VWF 
multimers to bind stably to circulating platelets. This explains the ability of these VWF 
mutants to spontaneously agglutinate platelets in vitro at shear rates as low as 200 s
-1
 or 
in response to low concentrations of a modulator such as ristocetin (60). Our data 
demonstrate that the mutations directly affect the mechanical properties of isolated A1-
domain bonds with GPIbα, but they do not exclude an additional effect of the mutations 
to expose more A1 domains on VWF multimers. In vivo, the enhanced binding also 
agglutinates platelets, which depletes larger VWF multimers from plasma and may cause 
thrombocytopenia. Furthermore, flow exerts force on the VWF that agglutinates platelets, 
exposing the cleavage site for the protease ADAMTS-13, thus further reducing the larger 
VWF multimers (98, 99). Bleeding results from depletion of larger VWF multimers from 
plasma, limiting their availability for binding to collagen on disrupted vascular surfaces, 




Binding kinetics of type 2M VWF-A1 with GPIbα 
As opposed to the type 2B GOF mutants, type 2M mutants of VWF-A1 exhibited 
a loss of function in the SIPA and RIPA assay compared with WT A1. The type 2M 
VWD phenotype is characterized by a decreased platelet-dependent function of plasma 
VWF, associated with a normal multimeric pattern (100). It is of particular interest for us 
to use the single molecular technique to study the biophysical properties of these LOF 
mutants interacting with GPIbα, as compared with the GOF kinetics data described 
above. We hypothesized that the LOF mutants will exhibit different kinetics during 
binding with GPIbα.  
The AFM experimental setup and protocol was similar to that used in the previous 
GOF studies. The only difference was that we replaced the protein coated on the Petri 
dish surface by type 2M mutants. We have tried three type 2M mutants, which were 
V516I, G561S and P704S. Figure 5.15 shows the mean bond lifetime vs. force curve for 
GPIbα/V516I bond. It has several characteristics. First, the V516I LOF mutant also 
formed catch-slip bonds with GPIbα. Second, this catch-slip bond had an obvious shift 
towards larger force: WT-A1’s catch bond peaked at around 23pN, while V516I’s catch 
bond peaked at around 39pN. The peak lifetime values were about the same, giving ~0.25 
seconds and ~0.3 seconds for V516I and WT-A1, respectively. Third, the catch bond 
shifted towards larger forces, resulting in much lower lifetime at low force regime. The 
lowest point for the V516I curve at low force was at around 15pN, giving mean bond 
lifetime a value of around 0.04 seconds. In sharp contrast, WT-A1 gave a mean lifetime 
value of around 0.2 seconds at 15pN. Figure 5.16 shows the lifetime vs. force curve for 
another LOF mutant, G561S. It exhibited behavior similar to that of V516I, except that 














Figure 5.27: Mean bond lifetime vs. force of V516I LOF mutant (green) interacting 










Figure 5.28: Mean bond lifetime of G561S LOF mutant (blue) interacting with 
















Figure 5.29: Mean bond lifetime of P704S LOF mutant interacting with GPIbα, in 
comparison with GPIbα/WT-A1 bond. 
 
Figure 5.17 shows the bond lifetime vs. force data for the third LOF mutant 
P704S. Again, it exhibited a shift in the catch-slip bond as V516I and G561S did. The 
slip bond regime collapsed well with the WT-A1 data. 
Discussion 
Because all three LOF mutants showed the same shift of catch-slip bond, we 
believe this behavior for LOF might be a typical kinetics for other LOF mutants. It has 
been shown previously that at high shear rates of ~4000 seconds
-1
 none of the type 2M 
VWFs was able to induce any measurable aggregation compared with WT-VWF. And 
this loss of binding function was also similar for ristocetin- but not botrocetin-dependent 
platelet binding (100). This study suggested that type 2M VWFs resulted in VWF 
conformation change that made it insensitive to high shear rates and ristocetin. Botrocetin 
could induce a VWF conformation which is totally different from the conformation of 
VWF caused by ristocetin binding or high shear stress. Furthermore, botrocetin induced 
platelet aggregration in the presence of VWF is insensitive to WT VWF and type 2M 
VWF. In other words, type 2M mutants could cause a similar VWF conformation as WT-
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A1 in the presence of botrocetin, but not the same as the VWF conformation in the 
presence of ristocetin or high shear. And this conformational similarity could come 
directly from the A1 domain. Our AFM experiments were all done without any A1 
agonist, either botrocetin or ristocetin, or high shear condition. So the possibilities are 
that the three type 2M mutations had only slightly changed the conformation of the A1 
domain, induced minor change at the binding interface for GPIbα-A1 bonds, and thus 
shifted the catch-slip bond quantitatively. This hypothesis was partly supported by the 
observation that none of the three LOF mutants is located in or directly next to the 
GPIbα-binding site. Therefore, the mutant induced conformational change could only be 
allosteric. Further experiments could be done in the presence of agonist ristocetin, to 
resemble the A1 confirmation in high shear condition. The hypothesis would be that type 
2M mutant A1 would have a much decreased bond lifetime, or a much increased off-rate, 
over the WT-A1, when A1 adopts the conformation as under high shear rates. And the 
control experiments could be testing GPIbα-A1 binding kinetics in the presence of 
botrocetin.  
Our findings provide new insights for type 2B and type 2M VWD, illustrate the 
different binding kinetics of GOF and LOF mutants, suggest possible structural basis for 
these functional differences, and propose a working hypothesis for future experiments. 
Binding kinetics of VWF A1A2A3 domain triplet with GPIbα and collagen effects 
Previously, we studied the binding kinetics of the WT A1 domain, two of its 
GOF, and three of its LOF mutants with GPIbα. The A1 domain is the core for VWF 
binding with GPIbα. At the same time, the other domains of VWF could also potentially 
affect the binding kinetics of A1. To dissect the effects from the A2A3 domain, we 
studied the binding kinetics of the A1A2A3 domain triplet with GPIbα, which could also 
provide a comparison to our previous A1 data. Figure 5.18 shows the AFM 
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Figure 5.30: AFM measurements for GPIbα/A1A2A3 bond (pink square) lifetime, in 
comparison with WT A1 data (red diamond). 
 
Compared with the WT-A1 data, the GPIbα/A1A2A3 bond shows a similar catch-
slip transitional bond but with a different peak force and lifetime values. The peak force 
happened at ~35pN, larger than the WT-A1’s 23pN peak force. The peak lifetime value 
for this experiment was slightly higher than that found for WT-A1, giving 0.32 seconds. 
In the catch bond regime (<35pN), lifetimes were generally higher than those found for 
WT-A1, and this difference started to decrease in the slip bond regime, collapsing with 
WT-A1 data after ~60pN. Therefore, A1A2A3 gave higher lifetimes than A1 when 
interacting with GPIbα in the whole force range. 
 63
During the process of hemostasis, circulating plasma VWF gets immobilized on 
the surface of the sub-endothelium by binding with collagen fiber. The immobilization of 
VWF on collagen would serve as an anchoring point for platelet-expressed GPIb to bind, 
and trigger the succeeding thrombus formation to stop the bleeding. Therefore, collagen 
binding with VWF is a very important step for recruiting plasma VWF to the site of 
vascular injury and would be of special interest to study. The immobilization of VWF on 
the collagen surface would also possibly affect the conformation, thus the binding 
kinetics, of A1 or A1A2A3. It is also not clear whether immobilization on collagen would 
change the difference between A1 and A1A2A3 when binding with GPIbα.  
For AFM experiments, we used type III collagen (purified from human placenta) 
to coat the Petri dish surface. Collagen (10ug/ml) was physically adsorbed on the Petri 
dish surface overnight at 4
o
C. At the start of the experiments, excess collagen protein was 
removed by washing three times by PBS buffer. A1 or A1A2A3 protein (1ug/ml) was 
applied on the collagen-coated surface for 1 hour secondary incubation under room 
temperature. During this incubation for collagen to capture A1/A1A2A3, a dampened 
paper towel was used to keep the incubation spot from drying out. Similar to our previous 
protocol, a BSA coated AFM tip was used first to characterize the non-specific binding 
level at a certain distance from the Petri dish surface. After confirming low enough non-
specific binding frequency, the GPIbα coated AFM tip was loaded to run a force clamp 
program to harvest lifetimes at that distance. We have frequently observed long (>50nm) 
ascending phases, or dead zones, which might come from the length of collagen fiber. 





which is comparable to common antigen-antibody interaction. Therefore, this capturing 















Figure 5.31: Mean bond lifetime vs. force curve for GPIbα binding with A1 
captured by type III collagen (blue diamond), in comparison with WT-A1 data 
without collagen capturing (red diamond). 
 
Figure 5.19 above shows the lifetime vs. force curve for GPIbα binding with A1 
captured by type III collagen. Compared with WT-A1 lifetime data, collagen capturing 
has not changed the catch-slip transitional bond, but has resulted in a considerable shift of 
the curve. There was a further increase at the catch bond regime, reaching higher peak 
force (30pN) and lifetime (0.32 seconds) value. The slip bond regime was almost parallel 


















Figure 5.32: GPIbα-A1A2A3 bond lifetime vs. force curve with A1A2A3 captured 
by type III collagen (green square), in comparison with the data of A1A2A3 
physically adsorbed on Petri dish surface (pink square). 
 
Figure 5.20 shows the GPIbα-A1A2A3 bond lifetime vs. force curve with 
A1A2A3 captured by type III collagen, in comparison with the data of A1A2A3 
physically adsorbed on Petri dish surface.  The green squares show similarity to the A1 
data at the catch bond regime, and with shorter lifetime vs. the physically adsorbed 
A1A2A3. When the force was larger than 60pN, collagen-captured A1A2A3 exhibited 
much longer lifetime (~0.2 seconds at ~90pN) than both physically adsorbed A1 and 
A1A2A3 (<0.05 seconds at ~90pN) when binding with GPIbα. It is also interesting to 
notice that bond lifetime was insensitive to even high force level when using the collagen 











Figure 5.33: Collagen capturing effects on LOF A1 mutants G561S lifetime when 
interacting with GPIbα (green diamond), in comparison with physically adsorbed 
WT-A1 (red diamond) and G561S data (blue diamond). 
 
To study whether collagen capturing would have effects in type 2M LOF A1 
mutants, we also measured its lifetime with GPIbα (Figure 5.21). Interestingly, the shift 
observed for the G561S mutants was not observed for the collagen captured LOF 
mutants, that is, collagen capturing shifted the curve back to the WT-A1 curve. 
Discussion 
The above data shows a clear trend that, with the exception of the catch bond 
regime, collagen capturing prolonged the GPIbα-A1 lifetime. This bond lifetime 
enhancement was similar to A2A3’s effect on A1 (Figure 5.18), but had an impact on a 
broader range of force. Because GPIbα can only bind to the A1 domain, the lifetime 
difference could only come from the conformational difference of the A1 domain. The 
A2 domain has been revealed to be able to form coupling with the A1 domain, in other 
words, A2 could bind with A1 to shield the GPIbα binding sites. From our experimental 
observation, the binding frequency for GPIbα-A1A2A3 was comparable to GPIbα-A1 
binding. Therefore, it is highly possible that the coupling between A1A2, if there was 
any, has already been disrupted if this was the necessary step to expose A1’s binding sites 
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for GPIbα. If A1 and A2 were still coupled together, the GPIbα binding sites must have 
already been exposed during the experiments, which might be caused by the physical 
adsorption. The extra linkage of two A-domain could stabilize the GPIbα-A1 binding 
sites thus giving longer lifetime before ~60pN. On the other hand, type III collagen 
capturing enhanced the GPIbα-A1 bond lifetime at larger force range, but showed 
minimal effects at low force range. This difference in function would come from the 
different structural strengthen effects at the binding sites. Therefore, A1 could assume 
different conformations, each of which would also cause different binding pocket 
structure and therefore binding strength. From the sliding-rebinding model for explaining 
catch bond, another possibility would be the sliding-rebinding pathway difference for the 
various conformation of A1 domain. The difference in the number of hydrogen bonds 
along the sliding-rebinding pathway would obviously be a strong factor to affect the bond 
strength. The combination of data for A2A3 effects and collagen effects revealed that 
both could affect the conformation of the A1 domain and result in the prolonged lifetime 
at different force range. A2A3 caused longer lifetime at lower force range, i.e. at the 
catch bond regime. Collagen capturing induced more evident lifetime increase at larger 
force range, i.e. at the slip bond regime. The A2A3 and collagen effects could be 
additive. One observation is that there is no difference for lifetime at catch bond regime 
using the collagen capturing protocol, for either A1 or A1A2A3. 
It is also interesting for us to notice that collagen shifted the G561S lifetime curve 
back to the WT-A1 curve. This observation implies that collagen might cause the LOF 
A1 mutant to adopt a conformation similar to that of WT-A1. That is, the G561S A1 
mutant’s conformational change induced by binding to collagen might switch the 
molecule back to the original A1 conformation. Furthermore, it is a more dominant effect 
than the previous conformational change induced allosterically by point mutation. 
Considering the pathophysiological condition for VWF A1 binding GPIbα, LOF mutants 
need to bind to collagen to become immobilized on the subendothelial surface. Thus, our 
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current data has not observed any “loss of function” of the molecule, if collagen 
capturing is a prerequisite. This observation confirmed previous studies that type 2M 
mutant effects were only observable when the A1 molecule adopted a special 











BINDING KINETICS OF ADAMTS13 WITH VWF 
 
Introduction 
During the process of hemostasis, the size of ULVWF affects the affinity of VWF 
to platelets bearing GPIbα on the membrane. ADAMTS13 (A Disintegrin and 
Metalloprotease with ThromboSpondin motif) is a multi-domain metalloprotease that can 
cleave at the Tyr1605-Met1606 bond of VWF, thus regulating the size of ULVWF. 
Based on the available data from previous studies, a model of proteolysis was built as in 
Figure 6.1 to show the regulation of ULVWF size by ADAMTS13 cleavage under blood 












Figure 6.1: A potential model for ULVWF proteolysis by ADAMTS13 in vivo. 
(Adapted from (8)) 
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In this model, ULVWF secreted by the endothelial cell upon stimulation would 
anchor at the surface of the endothelium. The subsequent binding of platelets on these 
hyper-adhesive VWF multimers would transduce the shear stress into stretching force on 
VWF molecules. The stretching force would result in the exposure of the ADAMTS13 
cleavage site buried inside the A2 domain, thus facilitating the cleavage events. Smaller 
fragments of VWF would be released into the blood stream and would adopt a different 
conformation because of the concurrent release of stretching force after cleavage. This 
change in molecule conformation would make the released fragments resistant to 
cleavage because of the inaccessibility of ADAMTS13 to both/either the binding sites 
and/or cleavage sites in VWF. Deficiency of plasma ADAMTS13, either from inherited 
mutations or from an acquired autoimmune response that produces antibodies against 
ADAMTS13, could result in the malfunction of ADAMTS13’s function of reducing the 
size of ULVWF molecules and could cause systematic thrombotic microangiopathies 
such as thrombotic thrombocytopenic purpura (TTP) (93). TTP is a serious disease with 
high mortality which would observe formation of platelet thrombi within the 







Figure 6.2: Diagram of the VWF A1A2A3 domains. ADAMTS13 cleaves at Y1605-
M1606 peptide bond in A2 domain. (Adapted from (101)) 
 
VWF has a multi-domain structure which we have shown in the last chapter. The 
key binding sites for GPIbα are located inside the A1 domain and the ADAMTS13 
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cleavage site is located inside the A2 domain (Figure 6.2). The A3 domain may bind to 
ADAMTS13 to provide an anchoring point for the enzyme to target at the A2 domain. 
Since the discovery of ADAMTS13 seven years ago (102), extensive studies have been 
done to investigate the binding between ADAMTS13 and its substrate VWF. Most 
studies focused on the A1A2A3 domain because these domains are highly interdependent 
in regulating the exposure of the A2 domain’s cleavage site and ADAMTS13’s cleavage 
efficiency. Figure 6.3 below shows the domain structure of ADAMTS13 (103). It 
consists of the metalloprotease domain which is the enzymatic functional domain, 
disintegrin domain, TSP1-8 domains, Cys-rich domain, spacer domain, CUB 1-2 domain. 
Previous truncation studies of ADAMTS13 show that TSP1-8 repeats, the Cys-rich 
domain, the spacer domain and the CUB domains are all possible candidates to bind with 
the A1A2A3 domains (Figure 6.4). Therefore, the interaction of ADAMTS13 with VWF 
A1A2A3 is a convoluted problem, containing possible binding between different 






























Figure 6.4: Truncation study of ADAMTS13 constructs affinity with plasma VWF. 
Label at right shows the comparison of each specific construct’s binding affinity vs. 
full length (FL) ADAMTS13 molecule. (Adapted from (103)) 
 
ADAMTS13 belongs to the family of ADAMTS metalloproteinases which are 
frequently involved in the proteolysis of extracellular matrix proteins (103). The CUB 
domains are unique for ADAMTS13, which has been shown to interact with VWF (9, 
104). Although the in vitro data revealed that the ADAMTS13 truncation construct 
without CUB domains retained the same binding capability with human plasma VWF 
(103), the in vivo data showed the interaction between the CUB2 domain and VWF still 
played a major role in regulating ADAMTS13-VWF binding after partial unfolding of 
VWF (adding 1M urea). The difference between these studies implied the importance of 
physiological shear stress in affecting the ADAMTS13-VWF interaction. 
In this chapter, we study the binding kinetics of two ADAMTS13 constructs with 
the VWF A1A2A3 domain triplet, testing the binding force regulation of kinetics for both 
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interactions. These data would help elucidate the binding properties of ADAMTS13 with 
VWF. Our hypothesis is that full CUB domains (CUB1-2) can bind to VWF; and full-
length ADAMTS13 has different force regulated binding kinetics with A1A2A3 as 
compared with CUB1-2 domains. 
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Results 
CUB Domain Forms Slip Bonds with A1A2A3 Tridomain 
To test our hypotheses, we started by looking at CUB1-2 binding with A1A2A3. 
The spots labeled on the Petri dish surface were coated with 10ug/ml A1A2A3 in PBS 
buffer and kept overnight at 4
o
C. On the day of experiments, excess A1A2A3 was 
removed from the spot by PBS washing three times. Then the Petri dish was filled with 
5ml 1% BSA in PBS solution to block the non-specific interaction. At least two AFM 
probes were prepared by the same protocol to physically adsorb proteins on the AFM 
tips. One probe would be coated by 1% BSA and the other one by 10ug/ml CUB1-2. At 
the beginning of the experiments, the A1A2A3 coated spots were tested by the BSA 
coated AFM tip at a certain distance from the surface. Once it was confirmed that the 
non-specific binding was low enough (<5% for three consecutive points of the same 
spot), we loaded the CUB tip to test the specific binding. Usually, the specific binding 









Figure 6.5: Binding frequency comparison of specific (CUB-A1A2A3) vs. non-
specific (BSA-A1A2A3) interaction. Blue bars are binding with A1 domain and red 
bars are with A1A2A3 tridomain. 
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Figure 6.5 shows the typical binding frequency comparison of specific vs. non-
specific. Besides testing the specific binding between CUB and A1A2A3, we also tested 
the possible binding between CUB and the A1 domain. The data suggested that CUB 
could also bind with A1. Previous studies have shown that the VWF-A1 domain could 
inhibit the cleavage of A2 by ADAMTS13 and that this inhibition could be relieved by 
interaction of the A1 domain with GPIbα(105). Binding between CUB and A1 implied 
that ADAMTS13 might be also able to use CUB binding to A1 to relieve the possible 
steric hindrance of A1 on A2, possibly through uncoupling of A1 from A2. It thus might 
favor the exposure of a cleavage site in the A2 domain. As revealed by other studies, the 
A3 domain may serve as the anchoring point for ADAMTS13 to bind A1A2A3. 
Although we have not done the study to test possible binding of CUB with A3 or even 
A2, the CUB-A1 binding may also provide an additional anchoring point for 
ADAMTS13. The contribution of CUB domains to the ADAMTS13-VWF binding 
differs for the in vitro and in vivo studies, indicating the importance of A2 unfolding. The 
in vitro binding assay without A2 unfolding might favor more interactions between 
ADAMTS13 and VWF, minimizing the contribution from CUB domains. With A2 
unfolded and changing conformation, there might be fewer binding sites at the interface, 
thus maximizing the impact from CUB domains. The other possibility is that the 
conformational change of A1A2A3 and/or A2 from folded to unfolded condition would 
change the synergies for domains inside ADAMTS13, leading to the increased 
significance of the CUB domains’ contributions to the overall binding affinity. Recent 
studies also showed the spacer domain binds to the exosite near the C-terminal of the A2 





























Figure 6.7: Average lifetime dependence on force data shows CUB forms slip bonds 
with A1A2A3. 
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From the binding events of CUB with A1A2A3, we first quantified the rupture 
forces and made the histogram to evaluate the bond strength from rupture force 
distribution (Figure 6.6). All the experiments were done at 200nm/s loading rates. The 
histogram data peaks at ~15pN, and most data had rupture force values between 10pN 
and 55pN. Figure 6.7 shows the average lifetime measurements for CUB/A1A2A3 
interaction. It has a typical Bell model shape, indicating that a slip bond existed, i.e. 
increasing force shortened the lifetime. 
Full Length ADAMTS13 Forms Catch Bonds with A1A2A3 Tridomain 
After measuring the bond lifetime dependence on force for CUB/A1A2A3 
binding, we continued to measure the full-length ADAMTS13 binding with A1A2A3. 
The goal was to test our hypothesis regarding whether the other domains of ADAMTS13 
would affect the binding kinetics of the CUB domain. For the A1A2A3 coated petri dish, 
we characterized the non-specific and specific binding frequency dependence on 
distance. The distance here is calculated by subtracting the piezo position at the 
waiting/fishing stage (any point during this 500ms) from the start-to-contact point, which 
is the same as discussed in the last chapter. In Figure 6.8, the upper panel shows three 
binding frequency vs. distance curves that were used for averaging to calculate the 
specific binding frequency vs. distance curve shown in the lower panel. In contrast to the 
sharp decrease of non-specific binding (BSA-A1A2A3) frequency with increasing 
distance from the surface, the ADAMTS13 coated AFM tip had much slower decrease in 
the binding frequency when being brought away from the A1A2A3 coated surface. Based 
on these data, our experiments were started by testing non-specific binding frequency at 
>12nm distance from the surface. We would increase from 12nm until the averaged non-
specific binding frequency at three consecutive testing points for the BSA coated AFM 
tip fell below 5%. At 2nm and 4nm, the average specific binding frequencies were even a 
little lower than the non-specific binding frequencies. This came from the heterogeneity 
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Figure 6.8: Binding frequency vs. distance curves for non-specific (BSA/A1A2A3, 
solid diamond) and specific (ADAMTS13/A1A2A3, diamond) interactions. Data 
suggest 14nm will be enough to suppress the non-specific binding, while there are 
still ~20% specific binding. 
 
From observation of experiments, we found that ADAMTS13-A1A2A3 binding 
had certain obvious features. The most evident one was that there were many multi-force-
drop events. Figure 6.9 shows an observation of typical occurrence frequency of one, two 
and three-force-drop events when ramping ADAMTS13-A1A2A3 bonds. The experiment 
was done at ~20pN clamping force, and different force drop events were counted based 
on the ~20% total binding frequency. This observation was consistent for all seven points 
tested. Compared with the frequency predicted by Poisson distribution (assuming random 
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occurrence of one, two, three-force-drop events), our experiments observed many multi-
force-drop events, indicating the possibility of protein structural change or sequential 
breakage from multi-binding-sites interaction. It is highly possible that these findings 
represent A1A2A3 structural change, because the A2 domain could unfold even under 
low force levels (60). We will study the structural change of A1A2A3 in much more 


















Figure 6.9: A typical distribution of one, two and three-force-drop events when 
stretching ADAMTS13-A1A2A3 bonds (blue bars). For the same total binding 
frequency ~20%, Poisson distribution  predicts much lower frequency/probability 
for multiple bonds events (red bars), indicating there were other reasons causing 
multi-force-drop events. 
 
From 401 lifetime measurements, we obtained the mean bond lifetime vs. force 
curve as shown in Figure 6.10. It shows a clear trend of catch-slip transition, which forms 
a sharp contrast to the CUB-A1A2A3 bond lifetime data. It is interesting for us to notice 
that, if we divide the full-length ADAMTS13 molecule into CUB and delCUB (without 
CUB), the delCUB part would exert a negative effect in bond strength at low force, 
changing the slip bond into a catch bond. At larger force level, the effect from the 











Figure 6.10: Mean bond lifetime vs. force curve for ADAMTS13-A1A2A3 




One possible explanation for the sharp contrast at low force range could be as 
follows: at minimal force, delCUB would have much faster association rate (high on-rate) 
with A1A2A3. DelCUB thus competed and took advantage of binding to A1A2A3. 
However, delCUB could also have much faster dissociation tendency (high off-rate) at 
low force. On the other hand, the CUB domains had much less chance to bind A1A2A3 
at low force because of low on-rate and/or possible hindrance by delCUB/A1A2A3 
binding. Once bound, CUB would not be easily dissociated from A1A2A3 because of 
low off-rate at low force (slip bond). With the increasing force, delCUB’s on-rate would 
decrease, as would its off-rate (slip bond). The decrease of the delCUB on-rate made it 
easier for more CUB molecules to bind A1A2A3. Although the off-rate of CUB-
A1A2A3 would also decrease with increasing force, the off-rate’s absolute value would 
still be lower than delCUB-A1A2A3 off-rate. Consequently, for the ADAMTS13-
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A1A2A3 bond, we will observe a higher off-rate value (lower lifetime) than for CUB-
A1A2A3, but the difference quickly diminishes with increasing bond lifetime (i.e., 
decreasing off-rate) as force increases. After reaching a peak value of lifetime (lowest 
off-rate) because of this combinational effect, the on-rate for delCUB-A1A2A3 would be 
negligible and most binding and dissociation events would come from CUB-A1A2A3. 
That may be the reason why we observed similar behavior for ADAMTS13-A1A2A3 
interaction and for CUB-A1A2A3 at high force level. The above hypothesis could be 
tested using the delCUB construct, possibly by measuring off-rate (lifetime). If there 
were both delCUB and CUB in contact with A1A2A3 in the experiments, we would also 
use the molecular pattern from CUB-A1A2A3 data (contour length, spring constant, etc.) 
to map out the percentage of CUB-A1A2A3 interaction from the ADAMTS13-A1A2A3 
data. 
The other possible explanation for the above catch-slip transition would be to 
exclude the CUB-A1A2A3 interaction. The CUB’s role in contributing to ADAMTS13 
binding with A1A2A3 is still unclear; one possibility is that CUB was not involved in the 
ADAMTS13-A1A2A3 binding. This way, the catch-slip transition would be governed by 
the behavior of delCUB. This hypothesis is supported by the in vitro truncation constructs 
study in that TSP1-8 (delCUB) had negligible difference as full-length ADAMTS13 in 
the binding affinity with plasma VWF (103). To test this hypothesis, we can measure the 
lifetime of delCUB-A1A2A3 bond and see whether it behaves as the same catch-slip 
transition. 
ADAMTS13-A1A2A3 interaction is another example of a catch bond we 
observed besides selectin-PSGL-1 and GPIbα-VWF interactions. Besides this, the 
significance of observing this catch bond may be elsewhere. This is the first catch bond to 
be observed for the enzyme-substrate interaction. Enzymes are responsible for virtually 
all of the metabolic chemistry in the biological world. And nearly all enzymes are 
proteins (except ribozymes – catalytic RNA). The enzyme-substrate interaction can be 
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divided into two steps: enzyme binding to the substrate and chemical reaction. The 
substrate binding is a highly specific interaction largely determined by a special binding 
pocket that recognizes the amino acid side chains on the substrate. In the ADAMTS13-
A1A2A3 case, the binding interface may contain multiple binding sites between different 
domains of both ADAMTS13 and A1A2A3. Like ADAMTS13, there are many other 
enzymes circulating in the blood, like COX-2 and ACE, to name a few. COX-2 is 
involved in brain inflammation (107). The brain is dependent on highly regulated blood 
flow. Therefore, blood flow change during inflammation may also be important in 
regulating COX-2 function in the brain blood vessels. Angiotensin-converting enzyme, or 
ACE, plays a critical role in controlling blood pressure and is the target of common 
medications (108). Angiotensin is an oligopeptide in the blood that causes 
vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal 
cortex. It is also under the blood shear condition that ACE converts an inactive form of 
angiotensin into an active form by clipping off two amino acids. Therefore, our finding of 
an ADAMTS13-A1A2A3 catch bond shed light on this enzyme-substrate interaction 
topic and implied that there could be various molecular mechanisms that these proteins 
can utilize to regulate the binding kinetics under different blood shear conditions. 
Second, the ADAMTS13-A1A2A3 catch bond may serve as a recruiting 
mechanism for the ADAMTS13 to be captured to endothelial cell-anchored ULVWF 
from the rapidly circulating plasma. Our previous studies have shown that the L-selectin-
PSGL-1 catch bond could help recruit leukocytes to the sites of inflammation. GPIbα-A1 
catch bond could help recruiting platelets to the sites of blood vessel injury. Therefore, 
prolonging lifetime by increasing force could also help recruiting more ADAMTS13 to 
the sites of cleavage for ULVWF. It is still unclear how this shear force would be applied 
between ADAMTS13 and VWF. 
Third, this catch bond could inhibit the inappropriate adhesion of ADAMTS13 
with plasma VWF. For the L-selectin-PSGL-1 and GPIbα-A1 catch bonds, we found both 
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of them could prevent the unwanted aggregate formation of neutrophils (30) and platelets 
(29) in the blood stream because of the short bond lifetime under small bond force (small 
relative velocity in the blood). Current the ADAMTS13-A1A2A3 catch bond 
observations could also explain why the VWF and ADAMTS13 coexist in plasma with 
minimal cleavage of the former. Fast dissociation at low force may prevent substrate 
binding and thus may inhibit further chemical cleaving reactions. This line of reasoning 
might not be the only reason for preventing unintended cleavage, because VWF would 
also remain at folded states if the force level is low. 
In conclusion, we studied the force regulated binding kinetics of VWF A1A2A3 
triplet with two structural constructs of ADAMTS13, CUB and full-length ADAMTS13. 
They showed totally different bond behavior with varying force level, indicating the 
interaction between ADAMTS13 and A1A2A3 might have multiple binding sites and 
different binding sites may also contribute differently to the final binding kinetics. The 
finding of ADAMTS13-A1A2A3 catch bond shed light on the enzyme-substrate 






CLEAVAGE EFFECTS OF ADAMTS13 ON VWF 
 
Introduction 
As previously demonstrated, endothelial cells constitutively release small 
multimer VWF molecules and secrete ULVWF upon stimulation. If ULVWF is the 
substrate for ADAMTS13 cleavage, the enzyme should function only during endothelial 
cell activation. This reasoning suggests that the thrombotic episodes of TTP are not only 
caused by ADAMTS13 deficiency, but also require a triggering event that induces 
systemic release of ULVWF. 
Regarding the physiological condition for cleavage to happen, one question is 
begged: does ULVWF proteolysis require fluid shear stress? Shear stress has long been 
known as critical for platelets tethering to the subendothelial surface as the first step of 
the recruiting process at the site of vessel injury and of thrombus formation upon rupture 
of atherosclerotic plaques. The effects of shear stress on ULVWF may be positive or 
negative in that it can enhance the binding of ULVWF to platelets or it can facilitate the 
proteolysis of ULVWF by stretching the molecule to an open conformation. Supporting 
evidence for this hypothesis includes the following: First, denaturing agents such as urea 
are required for VWF cleavage by ADAMTS13 under static condition (109, 110), while 
the cleavage under shear stress occurs without such requirement (9, 111). Second, 
ULVWF strings could be cleaved a thousand fold faster under shear stress than under 
static condition (9). Third, electronic microscopy observation revealed that an arterial 
shear stress of 35 dyn/cm
2
 converts loosely coiled VWF multimer with ~0.3 µm diameter 
to an extended filament about 1-3 µm long (65, 92). This conformational change of the 
molecule may expose the cleavage site of a single peptide bond buried inside the A2 
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domain and shielded by A1 and A3 domains. This possibility is supported by previous 
studies showing that the recombinant A2 domain polypeptide could be cleaved faster and 
does not require urea, while cleavage of the recombinant A1A2A3 polypeptide is 
significantly slower (112, 113). Removal of the A1 domain also increases cleavage rate 
of VWF more than 10 fold (105). Further, the more opened-up conformation by shear 
stress may also facilitate the binding of ADAMTS13 to initiate the cleavage. Enhanced 
cleavage with similar efficiency has been observed for both plasma VWF under arterial 
shear stress of 34-48 dyn/cm
2
 (114) and ULVWF string at arterial (40 dyn/cm
2
) and 
venous shear stresses (2.5 dyn/cm
2
) (9). Therefore, using the single molecule method to 
study ADAMTS13 cleavage efficiency will provide important insights and direct 
experimental evidence to reveal how mechanical force plays an important role in 
regulating VWF cleavage by ADAMTS13. 
In this chapter, all the experiments are designed and finished by the author. I 
would like to thank Jiangguo Lin for his help with the data analysis. Without his help, it 










Experiment Setup and Specificity Control 
Using the Atomic Force Microsope (AFM), we measured the interaction of GPIbα 
or CR1 (mAb targeted at A1 domain) with VWF A1A2A3. The experimental setup is 









Figure 7.1: Experimental set-up for mechanically stretching VWF A1A2A3 by 
GPIbα (labeled blue) or CR1 (labeled purple). GPIbα or CR1 was physically 
adsorbed on AFM tip; A1A2A3 was either physically adsorbed on Petri dish, or 
captured by anti-6-HIS mAb pre-adsorbed on Petri dish. 
 
We used two experimental protocols to immobilize and stretch A1A2A3. In the 
first protocol, 10ug/ml A1A2A3 in PBS solution was physically adsorbed on a Petri dish 
surface and kept at 4
o
C overnight. On the day of experiment, excess A1A2A3 solution 
was washed three times by PBS buffer, and the Petri dish was filled by 5ml 1% BSA to 
block the non-specific binding. When running cleavage experiments with ADAMTS13 in 
the buffer, 200ul PBS buffer with 1% BSA and 5ug/ml ADAMTS13 was added to the 
spots with A1A2A3. A meniscus would form between the tip mount and Petri dish and 
the liquid inside the meniscus usually could last at least 3 hours for experiments before 











ADAMTS-13 and was also added in the buffer to serve as a control to see whether it 
could kill the cleavage effects. On the other side, GPIbα was also physically adsorbed on 
the AFM tip surface. The AFM cantilever (Veeco Instruments, Santa Barbara) was 
soaked in 10ug/ml GPIbα in PBS solution, incubated at 4
o
C overnight. The AFM tip was 
rinsed and soaked in 1% BSA for at least 30 min before the experiments. The A1A2A3 
coated spots on the Petri dish were tested using a 1% BSA coated AFM tip first to 









Figure 7.2: Anti-6-HIS mAb capturing A1A2A3 binds with CR1 but not with 
GPIbα. 
 
In the second protocol, we physically adsorbed anti-6-His mAb on a Petri dish 
surface by coating the labeled spots with 10-15ug/ml anti-6-HIS mAb in PBS solution 
under 4
o
C overnight. Excess solution was washed off the spots the next day and 20ul 5-
10ug/ml A1A2A3 was dropped on the spots for capturing. This secondary incubation was 
1 hour under room temperature, and wet tissue was covered on the Petri dish to keep the 
A1A2A3 solution from evaporating. Then excess A1A2A3 would be washed away and 
5ml of 1% BSA filled in the Petri dish to block the non-specific binding. 10ug/ml CR1 in 
PBS solution was used to soak the AFM cantilever as described above. A 1% BSA in 
PBS coated AFM tip was used to test the non-specificity of the A1A2A3 spots, and the 
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CR1-coated cantilever was used to stretch the A1A2A3. Different immobilization 
methods lead to different conformations of A1A2A3, and consequently affected their 
binding properties. GPIbα could bind with physically adsorbed A1A2A3 but not with 
antibody-captured A1A2A3. In sharp contrast, conformational sensitive antibody CR1 
could bind with anti-6-HIS captured A1A2A3, indicating the conformational differences 
for differently immobilized A1A2A3 (Figure 7.2). Mostly likely, physical adsorption 
“activated” A1 and exposed its GPIb binding sites, making it ready to bind GPIbα. 
Antibody capturing kept the A1 domain in the “inactive” state and it could only bind with 
CR1. The other possibility is that the physical adsorption disrupted the coupling between 













Force Clamp Experiments Detect Molecular Conformational Change 
With the above experimental set-up, we used a single molecular experiment to 
study the cleavage effects of ADAMTS13. We hypothesize that the mechanical stretch 
of VWF induces molecule conformational change and thus facilitates its proteolysis 
by ADAMTS13. Although this hypothesis has received some support (9) (92) (60, 114), 
these studies are thermodynamic measurements of protein unfolding by chemical 
denaturing reagents under equilibrium conditions. More direct and definitive evidence is 


















Figure 7.3: Force (navy) and piezo movement (red) vs. time data recorded by AFM. 
Panel A shows 1-force-drop lifetime t11 (time-to-rupture); B shows 2-force-drop 
having lifetimes t21 (time-to-unfold) and t22 (time-to-rupture); C shows 2-force-drop 
having only lifetime t21 (time-to-unfold); D shows 2-force-drop having only lifetime 
t22 (time-to-rupture). 
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Figure 7.3 shows the force clamp experiments we used to detect molecular 
conformational change and enzymatic cleavage effects. Panel A represents the single-
force-drop (rupture) event which has been used extensively in our previous 
measurements of bond lifetimes. The curve in navy color is a force trace of cantilever 
deflection over time, converted from the A-B voltage signal. The force clamp routine will 
be triggered once the pre-set force has been reached. The piezo voltage signal over time 
is also recorded as a red curve. The trigger point of the force clamp routine is the same 
point for starting lifetime recording and also the same point for the piezo to stop 
retracting. Once there is structural change or bond rupture, the force on the cantilever will 
decrease and the piezo will continue to retract until the final bond ruptures.  
Panel B recorded two lifetimes; we defined the first one as time-to-unfold and the 
second one as time-to-rupture. The second force drop could only be a bond rupture event; 
otherwise there would be a third ascending phase until final rupture. The first force drop 
could be unfolding or uncoupling, either of which is a catastrophic structural change of 
A1A2A3. And the time-to-unfold is the time recorded showing how long the structure 
can hold there before catastrophic structure change happens. In other words, it is the 
waiting time before unfolding/uncoupling. Panel C has time-to-unfold but no time-to-
rupture because the second ascending phase could not reach the preset force (~45pN) 
before the bond finally ruptured. Panel D does not have time-to-unfold and only has time-
to-rupture. Unlike panel A, panel B, C, and D all have two ascending phases, undergoing 
structural change before the final bond rupture. 
We first questioned whether these two-ascending phase observations were the 
results of two-bond rupture events. The following analysis has been done to rule out the 














Figure 7.4: Frequencies of occurrence of multiple force drops (number of breaks) in 
the raw force scan of stretching GPIbα-A1A2A3 bonds (Figure 7.3 only shows 
events with up to two force drops) compared with Poisson distribution prediction 
(Panel A). Panel B shows the comparison from experiments of L-selectin/PSGL-1 
interaction.  
 
First, we counted the number of multiple force drop events and compared the ratio 
of these events to the multi-bond break observations of other molecule systems and to 
that predicted by Poisson distribution. We analyzed the frequencies of occurrence of 0 
(no adhesion), 1 (Figure 7.3 panel A), 2 (Figure 7.3 panel B, C and D), and 3 (not shown) 
force drops in an ensemble of force-scan traces collected under identical conditions, and 
we compared the results to the Poisson distribution (Figure 7.4A). Poisson distribution is 
expected if multiple force drops represent multiple bonds (115, 116). When the total 
binding frequency (thus probability of no adhesion, or zero break) is matched, the 
numbers of 1, 2 and 3 breaks measured from the selectin experiment agree with the 
Poisson distribution (Figure 7.4B), suggesting that the sequential force drops represent 
sequential dissociation of multiple bonds in parallel (13). In contrast, we observed more 2 
and 3 force drop events in the VWF data (at the expenses of fewer single break events) 
than were predicted by Poisson distribution (Figure 7.4B, note the log scale used in the 
 92
ordinate). This is consistent with the interpretation that the sequential force drops 
represented sequential unfolding of multiple globular protein domains in series. Or, A1 
domain uncoupling from A2 domain could also contribute to these sequential force drops. 
 
Force-Extension Curves Exhibit Clear Patterns for A1A2A3 Conformational 
Change 
From the force-clamp data shown in Figure 7.3, we can convert the force trace 
over time into force vs. molecular extension curves based on force and piezo voltage 
signals, which are more straightforward tools for examining molecular signature or 
structural change patterns. The molecular extension value is calculated by subtracting 
cantilever deflection from the piezo movement. Force-extension curves are fitted by 




From the WLC model fitting, we can get fitting parameters including the Contour 
Length Increment. Figure 7.5 shows the alignments of 32 force-extension curves with the 
contour length increment ranging from <5nm to 80nm. In the upper panel, all the curves 
are aligned by the first ascending phase (black dots), leaving the second ascending phase 
spanning all around the space (color dots). In the lower panel, we separated the curves 
into three color schemes (blue, navy and green) based on the contour length increment 
histogram shown in Figure 7.8, which represented different contour length increment 
groups: 15-20nm, 45-50nm and 0-80nm. All the curves are still aligned by the first 

























Figure 7.5: Upper panel shows alignment of 32 force-extension curves for GPIb 
stretching A1A2A3. Two sample curves were taken to represent each 5nm contour 
length increment bin, and totally there are 16 bins in the range of 0-80nm. The first 
ascending phase (shown in black) was aligned and other parts of the curve not 
aligned (shown in color). Lower panel aligns 47 force-extension curves. Curves were 
separated into three color schemes: blue, navy and green, which represented 
different contour length increment groups: 15-20nm (navy), 45-50nm (green) and 0-
80nm (blue). This separation was based on the contour length increment histogram 
shown in Figure 7.8. 
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In Figure 7.5, the good alignment of the first ascending phase rules out the 
possibility of considerable conformational difference in A1A2A3 molecules because of 
the physical adsorption protocol. Because the AFM has spatial resolution of 1nm, 
A1A2A3 may still have small conformational variations in the sub-nanometer scale, 
beyond the resolution of our current experimental system. This similarity provided a 
uniform pool of A1A2A3 molecules for the pulling experiments. The aligned dots in the 
Y-axis direction result from thermal fluctuation of the A-B signal during lifetime 
recording. The piezo had stopped retraction but the cantilever was still vibrating, causing 
the A-B signal’s fluctuation. The calculated stretching force would also vibrate because 
of this.  
In the lower panel of Figure 7.5, although the WLC model gives similar contour 
length increments in each specific group, chances are that they still could be misaligned if 
obvious patterns did not exist. The curve shape was not solely determined by contour 
length increments. The second ascending phase of these curves formed two clusters, one 
at 15-20nm and the other one at 45-50nm; this is consistent with the following contour 
length increment histogram analysis. This clustering suggested there are molecular 
signatures underlying all these two force drop events. The first cluster was packed denser 

















Figure 7.6: Two ascending phase alignment of force-extension curves with contour 
length increments falls in between 15-20nm and 45-50nm. This method aligns both 
first and second ascending phases, which shows more clearly two patterns. 
 
We tried another aligning method. Aligning first ascending phase and second 
ascending phase, 15-20nm and 45-50nm contour length increment force-extension curves 
gave even clearer pattern as shown in Figure 7.6. This aligning method is implemented 
by the naked eyes and is more like a least-square-fitting method, trying to minimize the 
differences between different curves. Although the alignment of these force-extension 
curves was still qualitative, it provided us some insight into the different molecular 
behaviors observed from these two force drop events. Most importantly, from these 
insights based on experimental observation, we could form the proper molecular model 














Figure 7.7: Contour length increment histogram of GPIbα-stretching force-
extension curves. Contour length increment value is from Worm-Like-Chain (WLC) 
model fitting of force-extension curves. Histogram peaks at 15-20nm and 45-50nm. 
 
The above description has also been observed and confirmed from the contour 
length increment histogram analysis for GPIbα force-extension data. Figure 7.7 shows 
there are two major populations in the histogram. The highest peaks of these two 
populations are 15-20 nm and 45-50 nm, suggesting that most occurrences happen at that 
contour length increment. 
Furthermore, when steered molecular dynamics (SMD) simulations are used to 
unfold a model VWF-A2 structure, the results are consistent with thermodynamic and 
structural analyses, showing that among the three homologous A-type domains, A2 is the 
easiest to unfold because the N- can C-termini of both A1 and A3 are linked by a 
disulfide bond whereas A2 is not. The β-strands were observed to unfold sequentially, 












Figure 7.8: Force vs. N-to-C length plot of unfolding VWF-A2 domain by SMD 
simulation (by Wei Chen) 
 
The force level is much higher in the simulation than in the lab experiments 
because SMD must use much larger forces to accelerate the sub-second processes to 
nanosecond processes that are observable in computer simulations. Nevertheless, the 
simulated molecular length changes should provide some insights. The length of 20nm 
after the second force drop agrees well with the first peak value of the contour length 
increments value. This provides strong evidence for us to build a molecular model of the 
catastrophic structural change. 
Next, we measured the spring constant of the two ascending phases to further 
verify that these two force drop events are different from two bond rupture events that 
were observed before for L-selectin/PSGL-1 double bonds sequential rupture events 












Figure 7.9: VWF A1A2A3 structural change in two-force-drop events exhibit 
comparable spring constants for the two ascending phases which is different from 
typical double bonds sequential break as in L-selectin/PSGL-1 case. The second 
ascending phase has only half the elasticity of the first ascending phase for the 
double bonds.  
 
The sequential breakage of L-selectin/PSGL-1 double bonds resulted in half the 
value of spring constant for the second ascending phase as for the first ascending phase 
(Figure 7.9 right panel). In sharp contrast, for the roughly 200 measurements of these 
GPIbα-stretch force-extension curves with different contour length increments from 5nm 
to over 100nm, the second ascending phase has a similar or even larger spring constant 
value than the first ascending phase (Figure 7.9 left panel). Thus, it is more likely that 















Figure 7.10: Model for A1A2A3 catastrophic structural change from un-stretched 
state (middle): one pathway as uncoupling of A1 from A2 domain (left); another 
pathway as unfolding of A2 domain with A1A2 coupled (right). (by Wei Chen) 
 
Figure 7.10 shows a model illustrating how tensile force on A1A2A3 (applied by 
GPIbα or CR1 binding to A1) could induce uncoupling of the A1A2 or unfolding of the 
A2 domains before the final breakage of the receptor (GPIbα or CR1) ligand (A1A2A3) 
pair. The final breakage could be rupture of the bond or cleavage in the A2 domain when 
ADAMTS13 was present in the buffer. The above-mentioned catastrophic structural 
change and final rupture is a series of events that have been observed in the AFM force 
clamp experiments as shown in Figure 7.3. To study these catastrophic structural change 
events, we started by analyzing two force drop events because this is the basic building 
block for three-, four- or even more ascending phase events. Most importantly, analysis 
of two-force-drop events excludes those multiple force drop events that combine different 
kinds of structural change. The complexity of discerning specific structural change has 








events. It is most unlikely that uncoupling and unfolding would happen simultaneously. If 
both of these structural changes happen, there would be at least three force drops before 
final bond rupture. 
 
Discussion 
Naturally, A1A2A3 are packed with each other in the globular state, with the 
ADAMTS13 cleavage site shielded inside the A2 domain (Figure 7.10 center). Only until 
sheared by flood flow or surrounded by denaturing reagents like urea, will this cleavage 
site be exposed to ADAMTS13 (8, 9). The detailed molecular mechanism by which the 
A2 domain unfolds, binds to ADAMTS13 and is cleaved remains unclear. The A1 
domain would couple with the A2 domain (117), and the uncoupling of A1 from A2 
could result in a molecular extension around 15-20nm (Figure 7.10 left). The other 
possibility is that A1 still couples with A2 and that pulling A1 will induce A2 to unfold 
because of the force propagated from the coupling interface. From the SMD simulation 
we know that the A2 domain unfolding could undergo several steps, depending upon the 
pulling force and the loading speed. Different unfolding steps will generate different 
molecular extensions. Therefore, the contour length increment histogram would be the 
overlap of two extension histograms representing two possible structural changes, 
namely, uncoupling and unfolding extension. The first peak of the contour length 
increment histogram would also be the summation of these two kinds of conformational 
change, rather than solely the uncoupling pathway’s signature.  
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Analyzing ADAMTS13 Effects on GPIbα Binding to A1A2A3 Tridomain 













Figure 7.11: ADAMTS13 effects on the running frequency of GPIbα binding 
A1A2A3 in the absence (square), presence (diamond) of ADAMTS13 and EDTA 
(circle). The above three curves all have 26% total binding frequency in 100 
contacts. The bottom curve (solid diamond) has an initial binding frequency of 20%. 
Each curve is based on average of three individual curves. Error bars are standard 
error of the mean. 
 
To dissect the ADAMTS13 cleavage effect, we started by analyzing the binding 
frequency because this is one of the first read-outs from the experiments. Experiments 
with similar final binding frequencies (out of 100 contacts) of around 26% were taken in 
the comparison. For each curve in Figure 7.11, we averaged three running frequency 
curves. From the data we can see that, before adding ADAMTS13, the binding frequency 
gradually decreases from 40% to 26% (square). This decrease could be due to the gradual 
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depletion of molecules adsorbed on either surface of the AFM tip or the Petri dish. This 
observation of gradual decrease in binding frequency was consistent with our previous 
observations in using AFM to study L-selectin binding with 2-GSP-6 and 6-sulfo-sLex, 
and GPIbα binding with VWF A1. Although the strength of physical adsorption is very 
strong compared with receptor-ligand interaction, chances are that some molecules will 
be detached from the surface or gradually lose functionality. This depletion of function is 
not obvious when the coating density is high. Compared with the condition in the absence 
of ADAMTS13, the running frequency of binding decreased sharply from ~80% to ~40% 
in less than 50 touches for the condition in the presence of ADAMTS13 (diamond). After 
70 touches, the running frequency was similar to the control level. Adding EDTA in the 
buffer inhibits the function of ADAMTS13. The initial binding frequency of 35% can last 
100 contacts, gradually decreasing to the final binding frequency of 26% (circle). 
Because we are comparing three curves with similar final binding frequency (~25%), the 
initial binding frequency could be very different, which is shown in Figure 7.11. In other 
words, only those experiments with initial binding frequency as high as 80% could 
survive the sharp drop and reach the final 26% binding frequency. This sharp drop in 
binding frequency indicates that the cleavage effects were very obvious in our 
experimental observations. If the initial binding frequency is ~80%, the condition with 
the absence of ADAMTS13 will have much higher final binding frequency compared 
with the condition in the presence of ADAMTS13 (data not shown). Furthermore, for the 
case in the presence of ADAMTS13, if the initial binding frequency is ~20% (solid 
diamond), it would also decrease sharply to the background level binding of 5% in just 20 
contacts.  
There could be several reasons for the sharp drop in binding frequency. The direct 
explanation is that the physically adsorbed A1A2A3 lost functionality to bind GPIbα on 
the AFM tip. When the GPIbα coated AFM tip picked up A1A2A3 by binding to the A1 
domain, the A2 domain was also stretched, regardless of whether A1 was coupled to A2 
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at that time. If the A2 domain unfolded and was cut by ADAMTS13, the A1 domain 
would also detach from the rest of the A2 domain. Part of the A2 domain with the whole 
A1 domain (labeled as A1A2*) would detach from the petri dish surface. With the 
ongoing experiment, more and more A1A2* would be chopped off their anchoring 
points. Most likely, the anchoring point would be the A3 domain. It could also be the A2 
domain itself, if the A2 domain is adsorbed to the Petri dish by certain chance. If the 
anchoring points lay on the A1 domain surface, the ADAMTS13 would not have any 
chance to cut the A2 domain before the A1 domain was peeled off the surface. This is 
most unlikely because we observed many multiple force drop events and binding 
frequency dropped obviously after these multiple force drop events. The above 
speculation is based on the assumption that the A2 domain has to unfold upon stretching 
before it can be accessed and cut by ADAMTS13. 
After cleavage, the A1A2* could still bind to GPIbα if the final force drop was a 
result of cleavage. This type of binding could last much longer than the binding obtained 
under the forced condition. Or it could also be short, if low force shortened the lifetime of 
the bond between GPIbα and A1A2* when there is a catch bond behavior. The GPIbα 
binding site for A1 could be blocked by A1A2* if this cleavage product still remained on 
dock. The analogy is that the bait is still being occupied by a half fish, so other fish 
cannot bite. Thus, the binding frequency will drop when more and more A1 binding sites 
on GPIbα are occupied by A1A2* with the progression of cleavage. Compared with the 
first reason for A1A2A3 depletion, this effect is not as obvious, although it could also 
contribute to the binding frequency drop when doing experiments at a specific point. If 
we changed the point on the Petri dish for the experiment, the initial binding frequencies 
were comparable. This provides strong evidence that it is the A1A2A3 coated points that 
were losing functionality. Only after several hours of experimentation (after changing ten 
points) would we find that the AFM tip also lost functionality. 
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Figure 7.12: Contour length increment histogram of GPIbα-stretch A1A2A3 force-
extension curves (in the presence of ADAMTS13). Contour length increment value 
is from Worm-Like-Chain (WLC) model fitting of force-extension curves. 
Histogram peaks at 15-20nm and 40-45nm. 
 
Then we compared the extension histogram for those two force drop events after 
adding ADAMTS13 in the buffer. Figure 7.12 shows that the extension histogram is 
similar to the extension histogram in the absence of ADAMTS13. There are still two 
major populations of extension. The highest peak is still 15-20nm. However, there are 
also obvious shifts from large extension values to small extension values. There are 
almost no events with extensions over 70nm (only 1% at 90-95nm).  
In Figure 7.7, there are a considerable number of events with extension over 
70nm. Most bars in the low extension (<35nm) regime have higher percentage. Because 
we are analyzing the extension values from Worm-Like-Chain model fitting, if the AFM 
tip picked the same type of A1A2A3 molecules from the Petri dish, the comparative 
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extension values for cases in the presence of ADAMTS13 would not differ much from 
those measured in the absence of ADAMTS13, because the cleavage would only happen 
during the second ascending phase in our analysis method. The current data suggested 
that the AFM tip was picking up a different batch of molecules which had smaller 
extension values. Where were the molecules with longer molecular extensions? Most 
likely those with longer extension values had already been cleaved and only those with 
shorter extension values were left uncleaved. This could be because different kinds of 
conformational changes would create different accessibilities for ADAMTS13. And the 
molecule population with shorter contour length increment would be less vulnerable for 
ADAMTS13 and thus could better survive the cleavage. When those molecules with 
longer contour length increments had been cleaved and the percentage of those with 
shorter contour length increased, we could observe the shift of this extension to smaller 
values. The histogram still exhibits two similar populations, with percentage peaks at 
similar locations. This indicates that the molecules keep similar behavior when 
undergoing conformational change. 
Then we continued to analyze the survival rate of the second ascending phase 
before and after adding ADAMTS13 and EDTA. The survival rate is calculated by 
counting how many percentages of two-force-drop events have the second lifetime 
recording as shown in panels B and D of Figure 7.3, that is, the survival rate represents 
the percentage of second ascending phases that reach the clamping force. The data is 
shown below in Figure 7.13. In this analysis, we separate the data into two categories by 
contour length increment <35nm and >35nm. This separation is based on two populations 
in the extension histogram shown in Figure 7.7 and Figure 7.12. From our model, we 
hypothesize that most two-force-drop events with extension below 35nm are uncoupling 
events, and those with extension above 35nm are mostly unfolding events. Based on this 
hypothesis, the cleavage effect would be minimal for the first extension group because 
uncoupling of A1 from A2 would not expose the cleavage site in the A2 domain. 
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However, A2 domain unfolding would expose the cleavage site; thus the cleavage effect 
will be most evident for the second group with extension value larger than 35nm. The 
data in Figure 7.13 support our hypothesis. 
 


























Figure 7.13: Fraction of t22 events in the absence (open bars) and presence (dotted 
bars) of ADAMTS13, and EDTA (hatched bars). Analysis is separated into “short” 
(putative uncoupling) and “long” (putative unfolding) groups which have contour 
length increment <35nm and >35nm, respectively. Numbers labeled are p-value for 
paired t-test. 
 
Figure 7.13 shows the fraction of t22 events for GPIbα-stretch VWF A1A2A3 in 
the absence and presence of ADAMTS13, and EDTA. From all the two force drop 
events, we counted the percentage of those events that reached the preset force value and 
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the given lifetime recording. This is another bond strength measurement which is 
different from a lifetime measurement. It could also provide information on cleavage 
because cleavage that happens either during the ramping or after the ramping (during 
lifetime recording) would both affect the survival rate of t22. First, adding ADAMTS13 in 
the buffer decreased the ability of molecules to reach the preset force value from about 
62% to 55% for short extension (<35nm). This percentage decrease was larger (from 43% 
to 33%) for long extension (>35nm). It strongly supports our hypothesis that unfolding 
facilitates cleavage because long extension events had higher possibility of unfolding. For 
the unfolding events, the cleavage could happen either during the second ramping, or 
after the bond survived the ramping and gave a lifetime recording. Both cases would 
decrease the t22 survival rates: the first one lowered the survival rate directly and the 
second one would decrease the number of those molecules which have the potential to 
survive the ramping.  
There were still unfolding events having short extension, but the possibility is 
much lower. Instead, more uncoupling events would fall into this category. Adding 
EDTA rescued the survival rate of T22, leaving an even higher percentage for the long 
extension category. This over-compensation may result from the effects of EDTA on 
A1A2A3 structural change. Comparing the two categories, all the three situations 
(without ADAMTS13/with ADAMTS13/with ADAMTS13+EDTA) for long extension 
had lower survival rates than those of short extension. This trend indicates that more 
events after uncoupling could survive the succeeding ramping. Longer extension does not 
provide any benefits over surviving the ramp because the longer time for longer 
extension would subject the molecules to either rupture or cleavage. The putative 
unfolding would also increase the molecule’s contour length and thus lengthen the 
pathway for force propagation. 
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Figure 7.14: Average t22 comparison for the condition in the absence (open bars) 
and presence (dotted bars) of ADAMTS13, and EDTA (hatched bars). As Figure 
7.13, analysis is separated into “short” (putative uncoupling) and “long” (putative 
unfolding) groups which have contour length increment <35nm and >35nm, 
respectively. Numbers labeled are p-value for paired t-test. 
 
Similar to the analysis above, we averaged the lifetime t22 of those events that 
survived the ramping. Both short and long extension events exhibited obvious effects. For 
the short extension case, adding ADAMTS13 shortened average t22 from 0.21 second to 
0.17 second. EDTA brought the t22 back to the initial level. For long extension events, 
adding ADAMTS13 shortened the average t22 from 0.24 second to 0.12 second, only half 
the initial level. Similarly, adding EDTA brought the average t22 back to the comparable 
level. The small decrease of t22 indicates that there could still be cleavage effects with 
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short extension but that small extension did not favor cleavage effects. However, long 
extension favors cleavage and cleavage effects were most evident with conformational 
change at a larger scale. The average t22 of short and long extension events were at 
comparable levels, before adding ADAMTS13. However, Figure 7.14 shows that 
considerably less two-force-drop events could survive the second ramping and give a 
lifetime recording. The implication is that, although it is hard for longer extension events 
to reach the preset force, the bond would still maintain the same strength once it climbed 
up the ‘hill’. In other words, the force history does not have much effect on the bond 
lifetime before adding ADAMTS13 in the system. The effect on GPIbα/A1A2A3 bond 
lifetime was also minimal for the kind of conformational change that happened before the 
t22 recording.  
The sharp contrast between the average t22 of short and long extensions after 
adding ADAMTS13 are strong evidence for observing the cleavage effect. From the 
structural point of view, longer extensions would expose the cleavage site more and make 
it more accessible for ADAMTS13 cleavage. It is still not clear whether the cleavage 
happened during second pulling phase or during lifetime recording after the molecule was 
pulled to the preset force. One thing definitive is that cleavage took place during lifetime 
recording and caused an evident decrease in average t22. As discussed previously, this 
cleavage could also result in a lower survival rate of t22 events because cleavage affected 
the pool of molecules available during the experiments. It is still not clear to what extent 
the A2 domain should unfold before the cleavage site can be exposed for ADAMTS13. It 
is also highly possible that cleavage would occur during the second ascending phase, 
especially for the long extension events. This second type of cleavage would not affect 
the average t22 but would affect the survival rate of t22. Potential A1A2A3 candidates for 
t22 could suffer from being cleaved before reaching the triggering points of the clamping 
force, thus decreasing the t22 survival rates. The longer the extension, the more possibility 
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for this type of cleavage to happen. Most likely, these two types of cleavage would both 
take place during the experiments, in a randomized manner. 
Because we use the Worm-Like-Chain model to fit the force-extension curve, 
chances are that those events with long fitted extension values have not been stretched to 
the same extension. The fitting gave only the patterns of conformational change, and we 
manually separated the groups in two patterns. Most likely, these two patterns represent 
uncoupling and unfolding pathways. In this regard, the uncoupling pathway did not favor 
the cleavage because the A2 domain structure would not be affected by A1 detachment 
from A2. If an uncoupling pathway has the short contour length increments, the real 
molecular extension increase would not benefit cleavage because the cleavage site on A2 
was always inaccessible no matter how far the A1 domain swung away from the A2 
domain. On the other hand, if the unfolding pathway adopts long contour length 
increments, the molecular extension in those two-force-drop events would help the 
ADAMTS13 to access the cleavage site. At this stage, we still cannot correlate the extent 
of the cleavage site exposure to the average t22 decrease because t22 is related to force 
level. If the force is high for t22, the molecular extension value would also be high and 
thus could induce longer unfolding of A2 and more exposure of the cleavage site. A low 
force t22 would give shorter molecular extension even under the long contour length 
increment category. Therefore, only after analyzing the force-dependent behavior of t22 
can we make a clearer comparison and offer a more detailed explanation of what 
happened during the cleavage process. 
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Figure 7.15: Panel C of Figure 7.3 illustrates the measurement of transition time (in 
dashed green oval) and rupture time (in dashed purple oval). 
 
To further study the conformational change that happened at short and long 
contour length increments, we analyzed the transition time of the first force drop and the 
rupture time of the second force drop of two-force-drop events, as illustrated in Figure 
7.15. Transition time represents how long the structure needs to adjust to the catastrophic 
structural change and to transit to the new conformation in response to the applied force 
after this structural change. Rupture time represents the time for the molecule to fully 
dissociate from the binding pocket or the time for the A2 cleavage site to fully break in 
the presence of ADAMTS13. This transition and rupture happened so fast that it only 
took a couple of milliseconds. 
The transition time and rupture time measurements are summarized in Figure 
7.16. Before adding ADAMTS13, the transition time is different for the “short” and 
“long” group of contour length increments. But there were no differences between 
rupture times for the two groups. This strongly implies that the catastrophic structural 
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changes for the “short” and “long” groups were totally different; even if the final rupture 
resulted from the same kind of structural change. As we explained previously, the final 
rupture could only be bond dissociation of GPIbα from the A1 domain of A1A2A3. So 
the rupture events would behave the same regardless what kind of structural change 














Figure 7.16: Average transition time (left panel) and rupture time (right panel) 
analysis for GPIbα-stretch A1A2A3 in the absence (open bars) and presence (solid 
bars) of ADAMTS13, and EDTA (hatched bars). Comparison is separated in two 
groups with short (<35nm) and long (>35nm) contour length increments. Numbers 
labeled between bars are p-value for paired t-test. 
 
It is interesting that structure transitions with shorter extension increments took 
more time than those with longer extensions. These two structure changes could be the 
same kind. After adding ADAMTS13, both short and long extension groups had 
shortened transition time, which indicates that ADAMTS13 facilitated the structural 
change and speeded them up. In the previous chapter, we discussed the binding between 
ADAMTS13 and A1A2A3. This binding of ADAMTS13 clearly has changed the 
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The relative comparison of transition time between the short and long groups after adding 
ADAMTS13 retained the same features as were found in the case without ADAMTS13, 
and it confirms this unique observation. Rupture time has also been shortened after 
adding the enzyme. This shortening could have a couple of explanations: one explanation 
is that the enzyme cleavage caused faster breakage of this linear linkage of molecules. 
Compared with the A1 dissociation from GPIbα, the breakage of the backbone covalent 
bond may need less time because the cleavage only happened between two specific 
amino acids (102). There are fewer atoms involved than in the receptor-ligand binding 
pocket. For the GPIbα-A1 interaction, there are more than ten hydrogen bonds involved 
in the binding pocket (68). And the dissociation may undergo a sliding-rebinding 
pathway which could be a potential explanation for the GPIbα-A1 catch bond mechanism 
(29). The other explanation would be the effect of ADAMTS13 binding to A1A2A3. 
ADAMTS13 could bind to the A3 or the A2 domain of VWF (103). And ADAMTS13 
itself is a large multi-domain protein whose binding site with A1A2A3 could also be 
multiple domains. This binding could easily affect the conformation of A1A2A3 and 
could induce binding pocket structural change, leading to accelerated dissociation of 
GPIbα/A1. As before, when adding ADAMTS13, there was still no difference between 
short and long extension groups in rupture time. 
Adding EDTA to the buffer inhibits the function of ADAMTS13. Killing the 
enzyme prolonged the transition time to the level even longer than the initial condition in 
the absence of ADAMTS13. This over-compensation brought by EDTA has also been 
seen for the T22 survival rate for the long extension group (Figure 7.13). The short 
extension group still has longer transition time than the long group, which is consistent 
with the transition time comparison in the absence and presence of ADAMTS13. The 
rupture time difference between the short and long extension groups is not significant, 
and the values are comparable to those obtained for cases before adding ADAMTS13. 
These data suggest that EDTA not only inhibits the cleavage function of ADAMTS13, 
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but most likely, it could also inhibit the binding of ADAMTS13 to A1A2A3. 
ADAMTS13 has to bind to A1A2A3 to cleave, and this could be the reason for transition 
time shortening. If ADAMTS13 still binds to A1A2A3 after adding EDTA to inhibit its 
function, the conformational change induced by ADAMTS13 binding would still remain, 
regardless whether ADAMTS13 could cleave or not. ADAMTS13 is a circulating zinc 
metalloprotease and its function is highly dependent on the metal ion. EDTA is a metal 
ion chelator. Therefore, EDTA could possibly affect the binding of the enzyme to its 
target, making ADAMTS13 totally lose its function. This could be tested by adding 
EDTA to the system of ADAMTS13 binding with VWF A1A2A3. 
 
Analyzing ADAMTS13 Effects on Force Regulated Binding Kinetics of GPIbα-
A1A2A3 Bonds 
I. ADAMTS13 Effects on One-force-drop Events t11 and Two-force-drop Events t22 
Previous analysis provides strong support for our hypothesis and our catastrophic 
conformational change model. However, as discussed above, to make more detailed 
comparison of cleavage effects, we need to examine the force regulated binding kinetics 
of GPIbα/A1A2A3 interaction in the absence and presence of ADAMTS13, and EDTA. 
We started from measuring the single bond lifetime as shown in Figure 7.17 (scatter 


























Figure 7.18: Single bond (one-force-drop) lifetime (time-to-rupture) t11 in the 
absence (square), presence (diamond) of ADAMTS13, and EDTA (circle); Error 
bars are stand error of the mean. 
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In the absence of ADAMTS13, GPIbα formed catch-slip bonds with A1A2A3 
(square). In Chapter 4, we have already shown that GPIbα forms catch-slip bonds with 
WT A1 and A1A2A3. These data confirmed this observation. In the low force regime, 
the average lifetime t11 increased with increasing force. The average t11 peaked at around 
35pN with 0.3 second lifetime value. The peak lifetime force is larger than the GPIbα-A1 
catch-slip bond, which is around 25pN, but the peak lifetime value is comparable. One 
possible explanation for this increase in peak force is that A1A2A3 molecules are longer 
than the A1 domain only. This lengthening of the molecule could affect the binding 
pocket structure and make it withstand larger force. Furthermore, the A2 domain could 
couple with the A1 domain, and this coupling could be a strong interaction (117). The 
A1A2 coupling could also affect the ability of A1 to bind with GPIbα. It is still not clear 
how this molecular lengthening and domain coupling affects the sliding-rebinding in the 
binding pocket, if explaining the catch bond in this diagram. 
Surprisingly, we found that adding ADAMTS13 did not affect GPIbα-A1A2A3 
catch-slip transition or the value of t11 in a statistically significant manner (diamond). 
This indicates that the ADAMTS13 cleavage effect could not be observed through 
comparing t11. Since t11 measures the lifetime before the bond start to rupture, it has no 
relation with catastrophic structural change inside the molecule. In other words, a single 
bond lifetime only deals with the strength of the binding pocket without any structural 
rearrangement. In the analysis and discussion of rupture time, we suggest that 
ADAMTS13 could bind to A1A2A3 during the process of stretching by GPIbα. And this 
binding could be one cause of the observed difference in rupture time. It is still possible 
that ADAMTS13 bound to A1A2A3 during the measurement of bond lifetime before 
rupture. It is more unlikely that the enzyme would bind to and detach from A1A2A3 
during the t11 measurement, because the force level remained unchanged during the t11 
measurement. With high possibility, instantaneous binding and detaching of ADAMTS13 
from A1A2A3 would cause conformational change of the A1A2A3 molecule, thus 
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causing fluctuation of force level of the GPIbα-A1A2A3. Therefore, chances are that 
GPIbα bound to A1A2A3 with or without ADAMTS13 bound. Even if ADAMTS13 had 
already bound to A1A2A3 before it was picked up by GPIbα, it also had no effect on 
GPIbα-A1A2A3 t11, which was shown by data in Figure 7.16. It is still not clear whether 
ADAMTS13 would affect the rupture time of GPIbα-A1A2A3. The previous difference 
of rupture time before and after adding ADAMTS13 could result from the effect of 
ADAMTS13 binding to A1A2A3. It could also result from the catastrophic 
conformational change of A1A2A3, or both. 
Adding EDTA did not affect t11 and this is expected (circle), because there is no 
effect of ADAMTS13 cleavage. The GPIbα-A1A2A3 bond is also metal ion independent. 
One complication in this discussion is what if ADAMTS13 was bound to A1A2A3 
during the t11 measurement. In this regard, adding EDTA would inhibit this binding. But 
because we had not tracked the instantaneous binding of ADAMTS13 on A1A2A3 using 
the current t11 analysis method, we would not be able to quantify this effect. But it will be 
helpful to analyze the rupture time in the absence and presence of ADAMTS13, and 
EDTA. If ADAMTS13 binding to A1A2A3 will affect the rupture time, and if that is the 
cause of the difference between Figures 7.14 and 7.15, then adding EDTA would affect 












Figure 7.19: Scatter plot of 333 lifetime measurements for GPIbα-A1A2A3 two-
force-drop time-to-rupture t22 in the absence of ADAMTS13. As shown in the 
lifetime population, there is very few data over one second. Therefore, we set one 
second as cutoff line for outliers. 
 
Because we did not observe any difference in the one-force-drop bond rupture 
lifetime, we started to analyze the two-force-drop events. According to our hypothesis, it 
is expected that no difference will be observed for single bond t11 though, because the A2 
domain hadn’t unfolded yet to expose the Tyr1605-Met1606 cleavage site. As defined in 
Figure 7.3, the time-to-rupture t22 is the waiting time before the GPIbα-A1A2A3 bond 
started to rupture. t22 happened after the catastrophic structural change. The data in Figure 
7.19 shows the scatter plot for all the measurements. The two-force-drop events are very 
specific bond features, and they are only part of the observation. Not all the two-force-
drop events had time-to-rupture t22 (Figure 7.3 panel C). Therefore, the productivity for 
harvesting t22 was much lower than for harvesting t11. The scatter plot also shows that the 
value for t22 distribution was in a much lower range than that for t11, suggesting the effect 















Figure 7.20: Average time-to-rupture t22 in the absence (square) and presence 
(diamond) of ADAMTS13, and EDTA (circle). Error bars are stand error of the 
mean. 
 
The scatter plot and average lifetime (square) shows the t22 curve also had a catch-
slip transition shape. The peak force for maximum lifetime is around 25pN, which is 
lower than the t11 peak force (~35pN). The peak average lifetime value is around 0.22 
seconds, lower than the 0.31 seconds of average t11. The slip bond regime looks flatter, 
and thus had a slower decrease than t11’s slip bond. All these differences in time-to-
rupture between one-force-drop and two-force-drop events indicated the strong effect of 


















Figure 7.21: Re-plot of average t11 and t22 for comparison. Both curves are from 
experiments done in the absence of ADAMTS13. 
 
For comparison, we plotted one-force-drop t11 and two-force-drop t22 together in 
Figure 7.21, because both of them measure lifetime before rupture. There are several 
observations from these data. First, structural change (A2 unfolding or A1A2 uncoupling) 
weakened the bond and thus shortened the bond lifetime (there is still no cleavage yet) in 
the whole force range (Figure 7.21). In this scenario, the first ascending phase of 
stretching and the catastrophic structural change had already applied force history on the 
binding pocket of GPIbα-A1A2A3. This force history had a negative effect on the 
bonding strength. Second, the catch-slip biphasic pattern has been retained and this 
implies that the effect of preloading force history was still quantitative but not qualitative. 
There could also be conformational changes in the binding pocket during the preloading 
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history, but this disruption has not been deterministic. If the sliding-rebinding model 
could still be applied to explain this t22 catch-slip transition, then the structural change 
would have only affected the hydrogen bonds’ number in the sliding pathway because 
some sliding-rebinding might have already happened before the final rupture started. 
Third, the shortening of t22 was not equal under each force level. In the comparison of 
average t11 and t22 values in Figure 7.21, the bond lifetime shortening was about the same 
at the low force (<25pN) regime. But this shortening effect decreased with force, starting 
from around 35pN, and was minimal at large force around 70pN. One possible 
explanation is that, after the preloading history resulting from the first ascending phase 
and the catastrophic structural change, the bond would not be as sensitive to force as 
before. This caused the slip bond regime to flatten towards more ideal bond behavior. 
From the structural point, the preloading history might have created some conformational 
change in the binding pocket and thus might have decreased the capacity for further 
conformational change in adjustment to the external forces. In other words, preloading 
would ‘prepare’ the structure to a force-favored conformation for future force loading, 
but at the expense of possibly breaking the hydrogen bonds which could be used by the 
structure to respond to the force imposed at the very beginning of loading; this would 
decrease the overall ability of the binding pocket structure to respond to a certain force 
level. This decrease in force resistance was obvious at the lower force level, but may not 
be of the same importance in the higher force level. 
Adding ADAMTS13 did not change the catch-slip transitional bond behavior for 
t22 but shortened the t22 in the whole force range, with maximal decrease occurring at low 
force levels. The first point of t22 in the presence of ADAMTS13 had only half the value 
of that in the absence of ADAMTS13. This t22 shortening in the presence of ADAMTS13 
decreased with increasing force until it reached a constant level after both t22 curves 
peaked at around 25pN (Figure 7.20 and Figure 7.21). Adding EDTA totally abrogated 
this t22 shortening. The t22 curve for addition of EDTA in the presence of ADAMTS13 
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collapsed very well with that representing no addition of ADAMTS13. Compared with 
single bond rupture lifetime t11 in Figure 7.18, these data revealed that ADAMTS13 had 
an obvious effect on two-force-drop events time-to-rupture t22, but had no obvious or no 
effect on one-force-drop events time-to-rupture t11. These data strongly support our 
hypothesis that catastrophic structural change in A1A2A3 is required for the 
ADAMTS13 function to cleavage at A2. This cleavage could be totally inhibited by 
adding the metal ion chelator EDTA in the buffer, indicating that the function of this 
metalloprotease was also strongly dependent on metal ion. 
The other possible explanation for these data is that the accelerated dissociation of 
GPIbα from A1A2A3 was due to the binding of ADAMTS13 to A1A2A3, but not to the 
cleavage from A1A2A3 of ADAMTS13. However, the single bond lifetime data in 
Figure 7.18 strongly disputes this argument. If the accelerated dissociation was from 
ADAMTS13 binding, then we should also observe it in the single bond lifetime 
comparison. In the previous chapter we showed that ADAMTS13 could bind to A1A2A3 
and actually form a catch-slip transitional bond in the whole force range. Therefore, it is 
unlikely that accelerated dissociation but not cleavage, facilitated by ADAMTS13, 
required A1A2A3 structural change. On the contrary, this quantitative shortening of time-
to-rupture was most likely from the cleavage effect of ADAMTS13 on A1A2A3, 
validating the necessity for structural change of A1A2A3 to expose the cleavage site 
Tyr1605-Met1606 on A2 domain. The other potential method to prove this cleavage is to 
collect the buffer after AFM experiments and to run the western blot to visualize the 
cleavage products. 
II. Tensile Force on GPIb-A1A2A3 Weakens ADAMTS13 Cleavage Effects  
To further quantify the ADAMTS13 cleavage effect on t22 shortening, we re-
analyzed the raw t22 data according to different bin sizes. The whole force range for the 
data was divided by the same force increment (5pN). On each force level, we tried 
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different force bin sizes for optimization as shown in Figure 7.22. Because the amount of 
data is limited, we could not use too small of a force bin size. Otherwise there would be 
too much fluctuation noise in the curve. With the increase of force bin size from 15pN to 
25pN, the average t22 curve (in the presence of ADAMTS13) became flatter because the 
averaging eliminated the large fluctuation. We do not want too much fluctuation as 
shown in 15pN bin size (green solid diamond). On the other hand, we don’t want too 
many details being flattened out as 25pN bin size (red) either. Therefore, a 20pN bin size 












Figure 7.22: Comparison of different force bin size effect on averaged time-to-
rupture t22 in the absence of ADAMTS13. When bin size increases from 15pN 
(green) to 20pN (navy) and 25pN (red), detailed variations become smoothed out. 
For each curve, force increment is set to 5pN. 
 
Figure 7.23 panel A illustrates the comparison of averaged t22 based on same bin 
size (20pN) analysis. Panel B shows the off-rate difference calculated from averaged t22 
difference. Off-rate is the reciprocal of average lifetime. Adding ADAMTS13 shortened 
the averaged t22 and thus increased the bond off-rate. The dependence of this off-rate 
 124
increase on force implies how the force regulated the cleavage effect of ADAMTS13. 
Figure 7.23 is another presentation of the data in Figure 7.20. ∆Koff decreased sharply at 
the low force level until it reached a plateau after 25pN. These data implied that the 
stretching force on GPIbα-A1A2A3 bonds had a negative effect in regulating the 




















Figure 7.23: Comparison of averaged t22 based on same bin size (20pN) analysis 




Discussions for The Above Data 
The force corresponding to t22 is not the force causing A1A2A3 catastrophic 
structural change, which corresponds to t21. Instead, it is the peak force before the bond 
rupture (refer to Figure 7.3). Therefore, the A2 domain cleavage site might have already 
been exposed and subjected to ADAMTS13 cleavage. Here the force contributed to the 
stretching of the A1A2A3 molecular peptide backbone which includes the Tyr1605-
Met1606 cleavage site. It is still unclear how this stretching force affected the orientation 










Figure 7.24: Trx reduction rate on disulfide bonds depends on stretching force on 
eight tandem repeat of I27 polyprotein. (Adapted from (118)) 
 
According to a paper published by Dr. Fernandez’ group (118), force decreased 
the reduction rate of Thioredoxin (Trx) on the eight disulfide bonds buried in eight 
tandem I27 (Ig) domains (Figure 7.24). In their model, they argued that if the thioredoxin 
had to bind I27 to reduce the disulfide bond, the reduction rate curve would flatten out in 
large force level. If thioredoxin could reduce the disulfide bond without binding to the 
substrate I27, the reduction rate curve would decrease first and would then increase again 
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like E. coli Trx, as shown in the figure. Our off-rate deduction result simulates the result 
of Wiita et al., also giving a negative correlation on force. Putting in the schematic of 
their model, the flattening of ∆Koff at large force of our result implied the ADAMTS13 
had to bind to A1A2A3 to cleave. In other words, ADAMTS13 could not function by 
attacking Tyr1605-Met1606 with the enzyme still isolated from its substrate. In the paper, 
Wiita et al. proposed a model to explain the negative regulation of reduction rate by 
force. The two sulfide atoms of the disulfide bond had to adopt a certain orientation (a 
kink from the backbone) with Trx for the reduction to happen. Stretching force 
straightened the backbone with the disulfide bond and hindered the formation of optimal 
orientation for reduction. A larger stretching force provided a higher energy barrier for 
adopting the optimal geometric conformation, thus decreasing the reduction rate. For the 
ADAMTS13 cleavage site Tyr1605-Met1606 in A2, there is still no crystal structure 
resolved, nor does the ADAMTS13 and the ADAMTS13-A1A2A3 co-crystal. 
Nevertheless, ADAMTS13 cleavage on A1A2A3 is also an enzyme-substrate interaction, 
which is similar to the Trx-I27 polyprotein interaction. Therefore, it is highly possible 
that Tyr1605-Met1606 would also assume a certain orientation with ADAMTS13 for the 
cleavage to happen. If the orientation does not favor stretching force, then we would 
observe negative regulation of cleavage by force. One major difference in the force 
regulated reduction rates vs. off-rate deduction is the force scale: we used much smaller 
force (ten fold smaller) than the Trx reduction of disulfide bonds. This difference could 
result from the different strength of molecules in resisting external force. The VWF 
molecule is subject to venous and arterial blood shear force. I27 is from the cardiac 
muscle protein titin, which has to possess much higher strength in the high frequency 
cyclic strain environment than the blood vessel molecule VWF. Previous studies also 
revealed the unfolding force for titin is much higher (several hundred pN) than what we 
observed for A1A2A3 (several ten pN) in the comparable loading rates (119).  
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Figure 7.25: Scatter plot of 207 measurements for GPIbα-A1A2A3 two-force-drop 
time-to-unfold t21 in the absence of ADAMTS13. As in Figure 7.19, we use one 
second cutoff line to filter out the outliers. 
 
After examining the effects of ADAMTS13 on time-to-rupture t22, we analyzed 
whether the enzyme also had any effect on time-to-unfold t21. The word “unfold” was 
used to represent universal catastrophic structural change, including the possibilities of 
A2 domain unfolding, of A1A2 uncoupling, or more. Figure 7.25 shows the scatter plot 
of 207 measurements of “waiting time before structural change” t21 with the absence of 
ADAMTS13. Figure 7.26 shows the averaged t21 based on random force bin. From both 
the raw data and the averaged results, we found that t21 had an even lower value than t22 
in the whole force range, not to mention t11. It was most difficult to harvest this time-to-















Figure 7.26: Average time-to-unfold t21 in the absence (square) and presence 
(diamond) of ADAMTS13, and EDTA (circle). Error bars are stand errors of the 
mean. 
 
Discussions for The Above Data 
Both figures show that t21 behaved as a catch-slip transitional bond, which is 
similar to t11 and t22. Adding ADAMTS13 and EDTA does not affect the binding kinetics 
qualitatively or quantitatively. It is interesting for us to find the catch-slip transitional 
bond behavior for the waiting time before catastrophic structural change. The structural 
change inside the A1A2A3 molecule possibly results from the inter-domain hydrogen 
bonds breaking between A1 and A2, or from the intra-domain hydrogen bonds breaking 
between secondary structures (eg: α-helix and β-sheet) inside the A2 domain. The former 
one would lead to A1A2 uncoupling and the latter one would cause putative A2 
unfolding. Currently, the t21 data shows the combinational behavior of these two possible 
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structural changes, which could also be the response of the A1A2A3 molecule to the 
external shear stress in the blood stream. In the last chapter, we showed the catch-slip 
transitional bonds for ADAMTS13 binding to A1A2A3. This is another example of 
combinational effects for multi-domain interaction. Putting in the schematic of the 
molecular mechanism for catch bonds, there could be several possibilities, including the 
sliding-rebinding model, the induce-fitting model, and more (120, 121). Most of these 
explanations include the breaking or formation of hydrogen bonds in the binding pocket. 
Essentially, structural change inside the molecule retains all the features of protein-
protein non-covalent interaction but only on a smaller scale. Currently, there are still no 
reports for the catch bond behavior for “structural change lifetime” inside a specific 
molecule. Our findings are uncommon in revealing this possibility and common in 
explaining the possible mechanism that underlies this behavior.  
The catch-slip transitional bond of t21 could be a protective mechanism for the 
A1A2A3 molecule in response to external shear stress. When the ULVWF molecules are 
first secreted into the blood stream and immobilized on the membranes of endothelial 
cells, they would be quickly cleaved by ADAMTS13 because the stretching force level is 
much higher when many platelets bind to these long strings of hyper-adhesive molecules 
(122). The intensive stretching imposed on the molecules could induce quick structural 
change inside the molecule, thus facilitating cleavage by ADAMTS13. This cleavage 
would produce many much smaller pieces of plasma VWF flowing with platelets inside 
the blood vessel, and these plasma VWF are much less adhesive for platelets than the 
ULVWF. On the other hand, the human body wants to limit the plasma VWF to a certain 
amount and size, not losing its normal function to bind platelets in emergency situations 
(like bleeding). Therefore, the size of plasma VWF would serve as a regulation 
mechanism to control the extent of cleavage. But how does the ADAMTS13 know that 
the plasma VWF is in the proper size? The key regulator could be the stretching force on 
VWF molecule. When the multimer VWF molecule size decreases from cleavage, the 
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number of platelet binding sites also decreases. A decrease in the number of platelets 
binding would cause a decrease in the stretching force on A1A2A3, leading to a 
prolonged time-to-unfold, making it more difficult for ADAMTS13 to access the 
cleavage site. This protection of the cleavage site at a smaller force level would help 
preserve the amount of proper size plasma VWF and would prevent further inadvertent 
cleavage.  
The catch bond regime might be another protection against unintentional 
cleavage. The first step of hemostasis is the recruiting of patrolling platelets to the site of 
vascular injury. Platelets then bind to VWF that is immobilized on the exposed 
subendothelium surface on which collagen has been expressed. The binding of the first 
batch of platelets provides substrates for more platelets to bind to form the blood clotting 
matrix, which consists of collagen, immobilized VWF, platelets, αIIbβ3 integrin, plasma 
VWF, fibrinogen, etc. At this stage, binding of immobilized VWF to collagen serves as 
the anchoring point for all the above substances. Binding of plasma VWF to activated 
αIIbβ3 integrin also creates bridges between platelets. These anchoring and bridging points 
do not want to be cleaved by ADAMTS13, even inadvertently, because of the stretching 
force on it. Therefore, increasing force prolongs the time-to-unfold, providing strong 
protection against the A2 domain from being cleaved by ADAMTS13 when it functions 
as an anchoring point. One argument for this catch bond is the short time-to-unfold at 
very small force level (<10pN). We think that at this small force, the A2 domain may 
unfold. But our studies also showed that ADAMTS13 also had a very short lifetime with 
A1A2A3 under low force. Consequently, ADAMTS13 may not have a chance to cleave 
A1A2A3 at low force level. From these discussions we can see that the force regulated 
cleavage is highly convoluted because of the number of proteins involved and because 
their functions are different under different shear force conditions (eg: immobilized VWF 
and plasma VWF). 
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The analysis for transition time shortening after addition of ADAMTS13 (Figure 
7.15) revealed that the possible binding of ADAMTS13 on A1A2A3 affected the 
duration of the molecular adjustment to the force after the structural changes but did not 
affect the molecule’s ability to have structural changes. This is reasonable because time-
to-unfold is a hundred-fold larger than the transition time. And the effects of other protein 
binding were not pronounced enough to affect the dissociation of strong inter-molecule 
interaction. But the additional mass change could be involved in the re-structure process 
after catastrophic structural change happened. 
From all the analysis and comparison of t11, t22 and t21, we reached the conclusion 
that only after structural change to A1A2A3 would the ADAMTS13 have effects on 
GPIbα-A1A2A3 binding, with the most likely the cleavage effects being to shorten the 
lifetime t22. As for the lifetime analysis depending on force, we continued analyzing the 
ADAMTS13 effects on t22 survival rates and on real molecular extension between two 
force drops. The rationale for these analyses is to build a correlation of these parameters 
with force and to provide additional evidence for ADAMTS13 cleavage effects.  
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Analyzing ADAMTS13 Effects on Force Regulated Extension and t22 Survival Rates 
of GPIbα-A1A2A3 Bonds 













Figure 7.27: Method for measuring S21: the actual molecular extension for the 
catastrophic structural change (first force drop), and S3: extension between two 
force drops. The forces corresponding to S21 and S3 are different: F21 for S21 and F22 
for S3. 
 
Figure 7.27 shows the method we used to analyze S21 and S3, the actual measured 
molecular extension (not from WLC model fitting) for the catastrophic structural change 
(first force drop) and the extension between two force drops, respectively. For S21, we 
picked the lowest point of the force-extension curve after the first force drop and 
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extrapolated the same force value of that point leftward. The point with same force value 

















Figure 7.28: Force dependence of S21 (upper panel) and S3 (lower panel), in the 
absence (navy diamond) and presence (red diamond) of ADAMTS13. S21 and S3 
exhibits different dependence on force. ADAMTS13 decreased both extension in the 
whole force range. The forces corresponding to S21 and S3 are different: F21 for S21 
and F22 for S3. (Refer to Figure 7.27) 
 
For S3, the extension between two force peaks would be measured. Figure 7.28 
gives the analysis results for S21 and S3, both showing decreases after the addition of 
ADAMTS13. Previous analysis shows there is no effect of ADAMTS13 on t21, but why 
could we still observe the shortening of S21? One possible explanation might be that 
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ADAMTS13 preferably cleaves molecules with long S21 (thus providing more exposure 
for the cleavage site); therefore it changes the population in our analysis and we 
measured those with short S21. A molecular population with short S21 will not necessarily 
give shorter t21 than those molecules with long S21; thus there is no difference observed 
for t21. 
Discussions for The Above Data 
Most likely, the molecular population with shorter S12 has undergone A1A2 
uncoupling events. These events would give molecular extensions that are more 
insensitive to force than the unfolding events because A1A2 uncoupling would only give 
15-20nm molecular extension based on our model (Figure 7.10). And this swinging out 
of the A1 domain from the A2 domain would not be as sensitive to force as the unfolding 
case because unfolding could have several steps depending on different force levels. This 
reasoning is also strongly supported by the observation that the S12 value falls precisely in 
the range of 15-20nm in the whole force range after adding ADAMTS13. 
S3 has longer values than S21 in the absence/presence of ADAMTS13. The 
shortening of S3 after adding ADAMTS13 could come either from the cleavage during 
ramping (second ascending phase) after unfolding, or from a selected population of the 
smaller extension group after gradual depletion of the long extension group. Combined 
with t22 and ∆Koff data, we found the ADAMTS13 cleavage effects were minimal on S3 
but maximal on t22 and thus on ∆Koff under low force. This observation suggests that in 
our analysis, most cleavage happens during the lifetime t22 recording. In other words, 
much less cleavage happened during the second ascending phase ramping, thus leaving 
S3 unaffected because cleavage happened during t22 recording. Why was there not much 
cleavage during the second ascending phase (revealed by ADAMTS13 S3)? Probably 
because the time was too short for ADAMTS13 to function before A1A2A3 survived the 
second ramping. Based on the 200nm/s loading rate, a 20nm extension after first force 
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drop would only take ~0.1 second, similar to the averaged t22 at around 10pN in the 
presence of ADAMTS13. Hence, low force would favor structural change (low t21) but 
would also cause a reduction in the time for the enzyme to function.  
Larger force induced shorter S21 but longer S3. The measurements of S21 were 
based on the force level of the first ascending phase and right before the second ramping 
started (Figure 7.27). Therefore, it also depends on the starting force level of the second 
ramping phase. Reductions in the force required for the second ramping to start, 
coincided with longer measurements for S21 (bottom line of the first peak). From the 
molecular fingerprints for putative uncoupling and unfolding, we found that the residue 
force (the force at the start of second ramping) level for putative uncoupling was 
obviously higher than those of unfolding (Figure 7.6). This could result from much less 
time being allowed for the structure to resume the zero force conformation after the 
smaller scale structural change of uncoupling than unfolding. The decrease of S21 on 
larger force F21 could come from a population shift from “uncoupling” to “unfolding”. It 
is possible that A1A2 coupling can withstand larger force than the A2 domain before 
structural change happens. Consequently, most of the putative “uncoupling” events 
would support a large F21 but would only give small S21, which was observed as the 
decrease in S21. This reasoning is consistent with data in the presence of ADAMTS13 in 
that cleavage does not affect uncoupling because the cleavage site is still buried inside the 
A2 domain, thereby the shortening effect on S21 is not discernible at large F21. 
S3 provided information for the ability of A1A2A3 to change configuration in 
response to the structural change that was inflicted from the beginning of the first force 
drop. S3 had a steeper slope increase between 20pN and 30pN, which could result from 
an extension population shift from more putative uncoupling to more unfolding events. 
With a high possibility, the increase of S3 by larger force value came more from the 
longer ramping phase than from the longer unfolding. With larger stretching force F22 
causing longer extension, the percentage of unfolding events increased at the same time. 
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The consequence of this would be lower residual force that facilitated even longer 
ramping. 










Figure 7.29: t22 survival rates vs. force comparison for the condition in absence 
(navy diamond) and presence (red diamond) of ADAMTS13. Error bars are 
calculated from standard deviations of binomial distribution in each force bin. 
 
Similar to the lifetime and molecular extension analysis, we tried to look more 
closely at the force regulated t22 survival rate, which could provide additional information 
on the cleavage effects and could help us understand more about the data from the 
previous analysis. In Figure 7.13, we analyzed the average t22 survival rate for the 
putative uncoupling and unfolding group (short and long). Again, the survival rate is 
calculated by counting the percentages of two-force-drop events that have the second 
lifetime recording as shown in panels B and D of Figure 7.3, that is, the percentage of 
second ascending phases reaching the clamping force. Figure 7.29 shows the comparison 
of t22 survival rates of GPIbα stretching A1A2A3 when in the absence and presence of 
ADAMTS13. 
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Including all the two-force-drop events regardless of giving lifetime t22 or not, the 
t22 survival rate indicated the GPIbα-A1A2A3 bonds’ ability to survive the ramping. 
Therefore this could be looked on as another measurement of bond strength. In the 
absence/presence of ADAMTS13, both conditions gave increasing t22 survival rates with 
increasing force at low force levels. In the absence of ADAMTS13, the curve (navy) 
reached a plateau at around 30pN, giving maximal survival rate values around 70%. 
Adding ADAMTS13 shifted the ascending curve (red) towards lower force level, with 
maximal survival rates at around 20pN. The peak value of the red curve is at the same 
level as the navy curve, suggesting ADAMTS13 would not affect the survival rates at 
high force levels. The ascending phase of survival rates was consistent with the 
observation of t22 catch bond behavior. Although more lifetime observations would not 
guarantee longer lifetime, the ability of the bonds to survive larger force ramping is 
another indication of increasing bond strength. The lowest force hardly supported lifetime 
events, thus giving a very low percentage count (near zero). The force level for the 
ascending phase coincided with that of the slope changing phase for S3 in the absence of 
ADAMTS13, indicating the possible population shift of structural change group from 
uncoupling to unfolding also had positive effects on survival rates. Nevertheless, both the 
putative uncoupling and unfolding events would not conflict with the catch bond 
behavior because they were both structural changes happening before the final bond 
rupture. 
Discussions for The Above Data 
The interesting observation of the survival rates’ increase at low force after 
adding ADAMTS13 implied that the possible ADAMTS13 binding to A1A2A3 actually 
“helped” the GPIbα-A1 bonds to survive the ramping and reach the preset force. We still 
need to bear in mind that all these happened after the A1A2A3 molecule endured 
catastrophic structural change. Compared with the survival rate data shown in Figure 
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7.29, the group with long contour length increments (putative unfolding) had much lower 
t22 survival rates averaged from the whole force range, and the group with short contour 
length increments (putative uncoupling) had about the same level of t22 survival rates. 
Although the t22 survival rates for “short” and “long” groups could behave totally 
differently, there were still fewer possibilities for more “long” group events to happen in 
the low force range. On the contrary, more putative uncoupling events than unfolding 
events could survive the second ramping and give t22 with force below 20 pN after adding 
ADAMTS13. And this may be the main reason for the increase in t22 survival rates with 
the presence of enzyme. Combined with t21 and t22 data, there would be a tentative 
explanation to cover these data. Because F21 will not be larger than F22 if there is t22 
surviving the ramping, a low force value for t22 will also correspond to a low F21 value, 
regardless of whether there is any t21 recording (Figure 7.3 panel B&D). These low forces 
would facilitate the structural change because time-to-unfold would also be low. In the 
situation that ADAMTS13 would shorten t22 most but not t21 under low force, the 
possible binding of ADAMTS13 on A1A2A3 would facilitate more uncoupling events of 
the A1 domain from the A2 domain. And this increased possibility for uncoupling events 
would enhance the t22 survival rates in the low force range. These uncoupling events 
could also accelerate the dissociation of A1 from GPIbα, causing the observed shortening 
of t22. With the increasing force, fewer uncoupling and more unfolding events happened, 
causing more ADAMTS13 cleavage events. These cleavage events would shorten t22 but 
not t22 survival rates.  From this discussion, we hypothesized that A1 would also form 
catch bonds with the A2 domain, because increasing force would prolong the coupling 
lifetime and make it harder to uncouple. 
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Analyzing ADAMTS13 Effects During CR1 Stretching A1A2A3 Tridomain 
I. Loading Rates Effects on CR1 Stretching A1A2A3  
After using GPIbα to stretch the A1A2A3 molecule, we also tried the CR1-stretch 
protocol as depicted in Figure 7.1. This protocol has an advantage in controlling the 
orientation of A1A2A3 molecules. When using direct physical adsorption, we could not 
guarantee the position of adsorption right at A3 domain. Another complication would be 
the partial unfolding of the A1 domain when it was adsorbed on the Petri dish and pulled 
by GPIbα. GPIbα binding to A1 could also be another factor to affect the unfolding of the 
A2 domain and the subsequent cleavage process. Using anti-6-His mAb eliminated the 
complication of direct physical adsorption because A1A2A3 would be captured by the 
antibody, leaving the target molecule suspended with the petri dish surface. The C-
terminal of A1A2A3 was engineered to have a His-tag that could be recognized by anti-
6-His mAb only. This could also possibly protect the molecule to remain in more intact 
state for the stretching test because physical adsorption would also “activate” the A1 
domain. This tentative activation might have some effects on A1A2 coupling. The other 
reason for choosing the CR1-stretch protocol is to eliminate the possibility of GPIbα 
unfolding. By changing to CR1, we would only focus on A1A2A3 catastrophic structural 
change because anti-6-His and CR1 antibody would be simple enough to serve only as 
molecular handler. The CR1-stretch experiments were started by using the same loading 
rate as GPIbα-stretch (200nm/s). Force vs. molecular extension curves for single- and 
two-force-drop events are shown below in Figure 7.30. Compared with those shown in 
Figure 7.3, these curves have much flatter slopes thus causing much longer extension in a 
given force level (average ~70 nm at around 20 pN). The slope is calculated to be around 
0.2 pN/nm, which is about only tenth of the GPIbα-stretch case. It is also hard for the 
CR1-A1A2A3 bond to survive the ramping at higher force level (<30 pN), implying 
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much weaker bond strength than the GPIbα-A1A2A3. We could still observe two-force-
drop events, giving us the hope of continuing to use this protocol. These features resulted 
from adding the molecule length in the series of molecules: anti-6-His mAb has a similar 
length as A1A2A3 (~10 nm) and thus would lead to at least double the length of 















Figure 7.30:  Force vs. molecular extension curves for single- and two-force-drop 
events when anti-6-His captured A1A2A3 was stretched by CR1. Loading rate is 
200nm/s, same as GPIbα-stretch protocol. These force scan curves show much 














Figure 7.31: Comparison of two-force-drop events S3 histograms under loading 
rates of 200 (green bars), 400 (red bars) and 600nm/s (navy bars). All experiments 
were done by stretching A1A2A3 using CR1 in the absence of ADAMTS13. 
 
To compare with GPIbα-stretch data, we increased the loading speeds from 
200nm/s to 400 and 600nm/s, which generated an obvious histogram shift shown in 
Figure 7.31. The molecular extension values here are S3, but not those fitted by the WLC 
model. The loading rate increase from 200nm/s to 400nm/s has a much more obvious 
effect in this shift than the increase from 400nm/s to 600nm/s. These data suggest that 
faster loading rates would give less time for the structure to respond to force and less 
space for conformational rearrangement. To further assess the loading rate effects on 
lifetime measurement, we compared the scatter plots of t11, t21 and t22, which were shown 
in Figure 7.32 and Figure 7.33. All three measurements showed obvious shifts from 
200nm/s to 400nm/s. Consistent with the molecular extension value, changing from 
400nm/s to 600nm/s didn’t have much effect in these measurements. The shifts of 
lifetime t11, t21 and t22 were all towards smaller force and much longer lifetime (upper-




























Figure 7.32: Loading rate effects on single-force-drop (single bond) lifetime t11 for 
CR1 stretching A1A2A3 in the absence of ADAMTS13. Upper panel shows t11 
scatter plots for three loading rates 200 (green), 400 (red) and 600nm/s (navy). 

































Figure 7.33: Loading rate effects on two-force-drop lifetime t21 (upper panel) and t22 
(lower panel) for CR1 stretching A1A2A3 in the absence of ADAMTS13. Both 






Discussions of The Above Data 
The analysis of averaged values of t11 shows there were almost no differences 
between the 400 nm/s and 600 nm/s loading speeds, which confirmed our observation in 
the scatter plots. t11 behaved as a slip bond, which is typical for antigen-antibody 
interaction (11, 12). One complication of our data is the dissociation of A1A2A3 from its 
capturing antibody. But this complication would not likely strongly affect the single-
force-drop t11 quantitatively because it was also an antigen-antibody interaction. 
Although the data amount for t21 and t22 were very limited for the 200nm/s loading rate 
because the bond strength was very weak at that speed, we could still observe the evident 
population shift towards lower force and higher lifetime value direction. t21 showed a 
clear catch bond shaped distribution for both 400 and 600nm/s loading rates. t22 showed a 
minor distribution shift from 400nm/s to 600nm/s loading speed. This observation is also 
consistent with previous studies in the Zhu lab, but with a very different loading rate 
range (Zhu lab unpublished data). Current data suggests that the molecule lifetime 
population would shift greatly with only a small increase in loading rates from 200nm/s 
to 400nm/s (or 600nm/s). t11 and t22’s quantitative difference in bond behavior imply the 
strong effects of structural change on CR1-A1A2A3 bond behavior. This impact could 
come from either the putative A1A2 uncoupling or the putative A2 unfolding. 
Considering that the only difference between t11 and t22 involved the loading history, the 
CR1-A1A2A3 bond had been pre-loaded before giving t22 recording. Obviously, this pre-
loading history has induced enough structural change in the binding pocket or in its 
vicinity to change the bond behavior. This reasoning conforms to our previous discussion 
of the difference between t11 and t22 for GPIbα-A1A2A3 bonds. Interestingly, comparison 
of t11 and t22 at the same loading rate gave the consistent observation that t22 was lower on 
average than t11 in the whole force range. Faster loading could result in higher “most 
probable rupture force”, which has been revealed by dynamic force spectroscopy (32, 
33). Under the schematic of this discussion, faster stretching by CR1 from 200nm/s to 
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400nm/s or 600nm/s could also enhance the bond strength at low force regime because 
CR1-A1A2A3 bond rupture lifetime was much higher. 
II. CR1-stretch Induced A1A2A3 Structural Change 
Because there was not much difference for t11, t21, and t22 between 400nm/s and 
600nm/s loading speed, we chose 400 nm/s as the standard loading rate for more 
experiments to harvest data for all the following analyses. Lower loading speeds were 
preferred for the AFM system in order to avoid possible hydrodynamic drag and signal 
delay in the system. As with the analysis we did for GPIbα-stretch protocol, we started by 
analyzing the contour length increments for CR1-A1A2A3 two-force-drop events. Figure 
7.34 shows the histogram of contour length increments from worm-like-chain fitting of 
each two-force-drop event and its comparison with GPIbα-stretch data. The histogram 
distribution doesn’t have much difference for both, giving a minor shift of the first peak 
from 15-20nm for GPIbα-stretch to 20-25nm. The position for the second peak was 
unchanged. This similarity in contour length increment strongly supported our hypothesis 
for the A1A2A3’s catastrophic structural change model, regardless of the stretching 
protocol used. This similarity also ruled out the possibility for GPIbα unfolding in our 
previous discussion. The small shift of first peak could result from the interference of 















Figure 7.34: Contour length increments histogram of CR1 stretching A1A2A3 (red 
bars), in comparison with GPIbα-stretch data (blue bars). Contour length 
increments were obtained from worm-like-chain model fitting of the original two-
force-drop events. 
 
Figure 7.35 compares the putative “uncoupling” and “unfolding” force-extension 
fingerprints with those of GPIbα-stretch data. Force-extension curves were chosen from 
the same bin of contour length increments fitted by WLC model, and they were from the 
same bar of the histogram shown in Figure 7.34. We still chose 15-20nm and 45-50nm 
contour length increments values for comparison. And they showed patterns with strong 
similarity to the GPIbα data. One observation is that CR1’s fingerprint for 15-20nm 
extension gave a much lower peak force at the first force drop than the GPIbα data. 
However, the second peak force was comparable to that of GPIbα. So the antibody 
capturing affected the A1A2A3 structure’s ability to resist the first force drop for the first 
type of structural change (“uncoupling”). The second type of structural change 
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(“unfolding”) gave a similarity in not only the pattern but also the first peak force value. 




































Figure 7.35: Comparison of CR1 “uncoupling” and “unfolding” force-extension 
fingerprints (navy dots) with GPIbα-stretch data (yellow dots). 
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Figure 7.36: Running frequency of CR1 binding to (stretching) A1A2A3, in the 
absence (square) and presence (diamond) of ADAMTS13. Error bars are standard 
error of the Binomial distribution. 
 
Similar to the analysis for GPIbα-stretch data, we analyzed the running binding 
frequency, t22 survival rate, average t22, transition time and rupture time for short and 
long contour length increment groups and the ADAMTS13 effects on these 
measurements. Figure 7.36 shows a typical experimental observation of running binding 
frequency. Similar to the GPIbα data, there was a slow and steady decrease in the binding 
frequency for more contacts between CR1 coated AFM tip and petri dish coated with 
anti-6-His captured A1A2A3. After adding ADAMTS13 in the buffer, an experiment 
with the same level of total binding frequency as before (~25%) would have much higher 
initial binding frequency, exhibiting a fast decrease in the binding frequency with more 
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contacts. This behavior illustrated the effects of ADAMTS13 in quickly decreasing the 











Figure 7.37: t22 survival rates (left panel) and average t22 (right panel) comparison of 
short and long contour length increment groups, with the absence (open bars) and 
presence (grey bars) of ADAMTS13. Number labeled are p-value of paired t-test. 
 
Figure 7.37 shows the t22 survival rate and the average t22 results for both 
conditions with the absence and presence of ADAMTS13. For the “short” contour length 
increment group, there were no significant differences between the two conditions, while 
there were significant differences for the “long” group. With the putative unfolding 
events, the t22 survival percentage had decreased by more than half after the addition of 
ADAMTS13. Interestingly, like the putative uncoupling events, the decrease in t22 
survival rates had not affected the average t22 value for the putative unfolding events. 
Therefore, the possibilities would be that the decrease in survival rates resulted from the 
accelerated dissociation or that cleavage occurred during the ramping phase instead of the 






































 pairs from left) comparison for putative “uncoupling” (or short) and putative 









 pairs are in the presence of 
ADAMTS13. Numbers labeled are p-value of each paired t-test. 
 
Figure 7.38 shows the analysis for transition time and rupture time of CR1 
stretching A1A2A3 two-force-drop events in the absence and presence of ADAMTS13. 
In the eight paired t-test, there is only one pair showing significant difference with 0.002 
p-value, which is transition time comparison between short (putative “uncoupling”) and 
long (putative “unfolding”) groups. Data shows the “unfolding” events have significantly 
longer transition time and more “uncoupling” events. This difference was abolished by 
adding ADAMTS13 in the system. GPIbα-stretch data shows “uncoupling” events have 
longer transition time than “unfolding” events (Figure 7.16), which is the reverse of CR1-
stretch data. The differences in the transition time and rupture time for GPIbα-stretch and 
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CR1-stretch protocols indicate that the duration of instantaneous structural transition of 
A1A2A3 could be affected by the ligand that binds to and stretches it. 











Figure 7.39: Scatter plot of 593 single-force-drop lifetime t11 of CR1-A1A2A3 bond. 
All experiments were done in the absence of ADAMTS13. Loading rate was 
400nm/s. 
 
To further elucidate the force regulation on the binding kinetics of CR1-A1A2A3 
bond based on one-force-drop and two-force-drop analysis when in the absence/presence 
of ADAMTS13, we continued analyzing the force dependence of the t11, t21, t22, t22 
survival rates, and molecular extension S3. Figure 7.39 shows the scatter plot of t11 
distribution on the range force in the absence of ADAMTS13 and Figure 7.40 shows the 
























Figure 7.40: Average single-force-drop lifetime (time-to-rupture) t11 in the absence 
(square) and presence (diamond) of ADAMTS13. 
 
Compared with the t11 measurements of GPIbα-stretch protocol, CR1-A1A2A3 
bonds gave lifetime measurements in a much smaller force range. The more compact data 
in the less than 40pN range exhibited a clear trend of slip bonds, which was typical of 
antigen-antibody interaction. Adding ADAMTS13 did not change the bond behavior 
either qualitatively or quantitatively. This was consistent with the observation from the 
GPIbα-stretch protocol. Because of the limited supply of CR1 antibody, we have not 
done the EDTA control as for GPIbα-stretch. And as discussed previously, we used 












Figure 7.41: Scatter plot of 229 two-force-drop time-to-rupture t22 measurements for 
CR1-A1A2A3 in the absence of ADAMTS13. One second cutoff line was set for 
filtering outliers. 
 
Figure 7.41 shows the scatter plots of two-force-drop t22 in the absence of 
ADAMTS13 and Figure 7.42 shows the comparison of force drop results before and after 
adding the enzyme. In the absence of ADAMTS13, t22 also showed a clear trend of slip 
bonds, which kept the feature of CR1-A1A2A3 bond but with quantitative differences. 
The difference implied the effects of catastrophic structural change. In sharp contrast to 
the t11 data, adding ADAMTS13 shortened the t22 value to only about one third of its 
original level and the curve of exponential decay became a flattened line, indicating 
insensitivity to force. The maximum shortening happened at the minimum force level, 
and this shortening decreased with increasing force until reaching near-zero difference at 
around 15pN. To further quantify this t22 shortening effect versus force, we did the 
analysis for averaged t22 again for a set force bin size, and we calculated the off-rate 

























Figure 7.42: Average two-force-drop t22 for CR1 stretching A1A2A3 in the absence 
(square) and presence (diamond) of ADAMTS13. Error bars are standard errors of 
the mean. 
 
Figure 7.43 shows the averaged lifetime analysis from 10pN force bin interval, 
and each data point was calculated at a 4pN increment from 2pN to 26pN. The ∆Koff 
value decreased from ~4.2/s at 2pN to near zero at 26pN, confirming our observation 
from the mean t22 data. The decrease of off-rate also had very similar trend as the GPIbα-
stretch data but at a much faster rate to reach near zero at a smaller force range. This 
similarity in the off-rate decrease dependence on force confirmed this unusual 
observation and also strongly implied the effects of ADAMTS13 on A1A2A3 regardless 



































Figure 7.43: Comparison of averaged t22 vs. force based on same bin size (10pN) 
analysis (upper panel) for the data of in the absence (square) and presence 
(diamond) of ADAMTS13. Lower panel shows off-rate difference vs. force 
calculated from the reciprocal of averaged t22. 
 
As discussed previously, the stretching force on A1A2A3 might have negative 
effects in facilitating the cleavage favored conformation of the cleavage site in the A2 
domain after catastrophic structural change. It was confirmed from repeated observations 
that higher stretching force on A1A2A3 resulted in smaller ∆Koff regardless of the 
stretching protocol before and after adding ADAMTS13. There might be differences 
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between the initial conformations of A1A2A3 because of different immobilization 
methods. But these possible conformation differences had not changed the effects of 
force in regulating ADAMTS13’s effects of changing the binding kinetics. At low 
stretching force levels, the possible binding of ADAMTS13 on A1A2A3 might show that 
it is easier to cut the Tyr1605-Met1606 bond or to accelerate the dissociation of CR1-
A1A2A3 bond. Also because of the longer t22 at low force level, the effects from the 
enzyme could easily be observed. At higher force levels, t22 might have already been too 
short for ADAMTS13 to function, either from cleavage or from accelerated dissociation 
of CR1 from A1A2A3. Comparing Figures 7.20 and 7-43, with adding ADAMTS13 in 
the system, we found the lowest t22 values at maximal force level (~80pN and ~30pN for 
GPIbα and CR1-stretch, respectively) for both stretching protocols were very similar, 
giving ~0.15 second value. For GPIbα-stretch, t22 was brought down from ~0.2 second. 
For CR1-stretch, t22 was already down to this level from the exponential decay. This 
similarity implied that 0.15 seconds might be the t22 threshold for observing the cleavage 
effect at large force. At the low force end, the even lower t22 value for GPIbα-stretch data 
might be the result of accelerated dissociation, as discussed previously. 
After analyzing the ADAMTS13 effects on time-to-rupture t22, we continue 
analyzing whether the time-to-unfold t21 has also been affected. Figure 7.44 shows a 














Figure 7.44: Average two-force-drop events time-to-unfold t21 in the absence 
(square) and presence (diamond) of ADAMTS13 for CR1 stretching A1A2A3. 
 
Discussion of The Above Data 
This interesting finding that the t21 catch-slip transitional bond remained 
unchanged for different immobilization and stretching protocols implied that the ability 
for A1A2A3 to resist the catastrophic structural change had not changed qualitatively 
because of protocols. This finding also confirmed our observation for GPIbα-stretch t21. 
The quantitative difference of t21 between GPIbα and CR1-stretch could come from three 
causes. First, the loading speed for CR1-stretch was 400nm/s while GPIbα-stretch was 
200nm/s. The faster loading rate could result in a quantitative shift of time-to-unfold. 
Second, different conformations of the A1A2A3 molecule because of different 
immobilization methods could cause the value difference. Third, different stretching 
positions because of different binding pockets on A1 for GPIbα and CR1 could result in 
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the t21 value difference. The conformation and binding pocket difference of A1A2A3 
could affect the way force was propagated through the A1A2A3 molecule to affect the 
strength of uncoupling or unfolding. For the uncoupling pathway, the above effects could 
be more obvious than the unfolding pathway, because the possible A1A2 coupling 
interface is located closer to the pulling site. The immobilization and stretching position 
difference could have less direct impact on the unfolding pathway because A1A2 
coupling might provide some shielding effect for the unfolding core. ADAMTS13 also 
had no effects in t21 for CR1-stretch protocol, implying the necessity of structural change 
before observing ADAMTS13’s effect. The possible binding of ADAMTS13 to A1A2A3 
seemed to have negligible effects on the catastrophic structural change t21. Most likely, 
both the uncoupling pathway and the unfolding pathway would not be affected. 
 
V. ADAMTS13 Effects on Force Regulated S3 and t22 Survival Rate 
To further dissect ADAMTS13 effects with two-force-drop observation, we 
analyzed the histogram and force dependence of molecular extension S3 as shown in 
Figure 7.45. The upper panel shows the shift of S3 from longer extension to shorter ones 
after adding ADAMTS13. The lower panel shows an obvious extension increase at force 
range 10-20pN. This extension increase could result from more unfolding events 
happening at larger force level. The extension increase was totally abolished by adding 























Figure 7.45: Histogram (upper panel) and force dependence (lower panel) of 
molecular extension S3 in the absence (blue bars and diamond) and presence (red 
bars and diamonds) of ADAMTS13. All experiments were done by using 400nm/s 
loading rate to stretch A1A2A3 molecule. 
 
Combined with t22 and ∆Koff data, low force test observations indicated more 
shortening of t22 and higher ∆Koff, but minimal extension S3 shortening; large force 
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induced minimal t22 shortening (near zero) but maximal shortening of extension S3. These 
observations implied that ADAMTS13 affected t22 duration but not the first force drop 
phase or the second ramping phase at low force. It is still not clear what percentage of t22 
events are impacted here. At larger force, ADAMTS13 would mainly target the ramping 
phase instead of the t22 recording phase. Therefore, t22 remained almost untouched, but 
the extension S3 had been shortened greatly. The reason why ADAMTS13 had this 
preference change for targeting at different force levels could be several fold. The first 
possibility would be the t22 percentage change: fewer t22 events at higher force level 
would result in fewer t22 shortening effects, but much more extension shortening effects 
would be observed. The second explanation could be in the time requirement for 
ADAMTS13 to function: if ADAMTS13 needed certain time duration to function, then 
the time before t22 triggering at low force would not be enough for the enzyme. At higher 
force levels, F22 was set to be much higher, so the ramping needed longer time, causing a 
longer extension S3 to reach the preset force and trigger the lifetime recording. The 
longer second ramping phase provided enough time for ADAMTS13 to function. For the 
second explanation, we do not have data to support it. However, for the first one, we 
quantified the t22 survival rate vs. force to support it. 
Figure 7.46 shows a clear decrease of t22 percentage with increasing force at 
600nm/s loading rate (green diamonds). The t22 survival rate was 100% at about 5pN and 
decreased to about 50% at 25pN. This decrease was in accordance with the bond lifetime 
t22 decrease with larger force, indicating the weakening of bond strength. Yellow 
diamonds are data from 200nm/s loading rates. As discussed previously, increasing 
loading rates would affect bond behavior quantitatively as the lifetime value shifted 
towards smaller force. This force history effect created a sharp contrast between 200nm/s 
and 600nm/s stretching speeds. Because of the limited data amount, we have not got the 
averaged t22 curve at 200nm/s loading rate yet. But the t22 survival rates suggest a catch-
bond-like behavior. It is still unclear yet whether this survival rates increase came from 
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the bond strength increase. It would be interesting to make more measurements at 
200nm/s loading speed and confirm this possible catch bond. Slower pulling could result 












Figure 7.46: Two-force-drop t22 survival rate vs. force for 200nm/s (yellow) and 
600nm/s (green) loading rate of CR1-stretch. GPIbα-stretch data (200nm/s loading 
rate) in the absence (red) and presence (blue) of ADAMTS13 was for comparison. 
 
The above observation confirmed our hypothesis for the maximal t22 change at the 
lowest force. Because the preset clamping force was low, almost all the two-force-drop 
events could give t22 recording. Consequently, the effects of ADAMTS13 would almost 
solely contribute to t22 shortening. With increasing force, the percentage of t22 events 
decreased, thus increasing the percentage of two-force-drop events which had not 
survived the ramping. t22 shortening effects also decreased with larger force, suggesting 
that the effects of ADAMTS13, if any, would target mostly on the ramping phase from 
either cleavage or accelerated dissociation. Recollecting the t22 shortening vs. force data 
for GPIbα-stretch, the effect of ADAMTS13 on t22 was maximal at low force even 
though t22 was minimal under softest stretching. Furthermore, the t22 percentage was also 
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the lowest at minimal force value (Figure 7.46 red diamond). Combining this with the 
observation that extension S3 was minimal at low force, we could draw the conclusion 
that the ADAMTS13 still mainly targeted at t22 even though there were fewer t22 events 
than in the CR1-stretch case.  
Therefore, the ADAMTS13 effects shared most similarities on t11, t21, t22, ∆Koff, 
S3, for GPIbα and CR1-stretch protocol.  And the most differences came from t11 and t22 
behavior and the t22 survival rates for both pulling methods. These similarities may come 
from the specific requirement for ADAMTS13 to take effects, and the differences may 
come from different bond behavior obtained by using different binding counterparts for 
A1A2A3. Nevertheless, all these similarities and differences complemented the whole 
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